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ABSTRACT 
In pigs, «P CD4+ and yô T cells constitute an important fraction of the circulating 
lymphocyte pool. This makes the pig an ideal animal model for functional studies of the two 
cell populations. A comparative evaluation of the systemic and mucosal responses of porcine 
CD4+ and yô T cells was conducted in the context of immunization and/or challenge with the 
pathogen Brcichyspirci hyodysenteriae. This spirochete causes a severe colitis in pigs; 
however, immunization with a pepsin-digested bacterin ameliorates clinical signs of disease. 
Protection has been associated with in vitro antigen-dependent proliferation of CD41" and 
yS T cells to B. hyodysenteriae antigens. A first set of experiments was conducted to evaluate 
the differential functional aspects of the systemic responses to B. hyodysenteriae antigens of 
CD41" and yÔ T cells. Results show that, while the proliferative responses of CD4+ were 
exclusively antigen-specific, y5 T cells responded to stimuli other than B. hyodysenteriae 
antigens. Proliferation of the two cell populations in vitro was dependent on the presence of 
IL-2. In addition, examination of IFN-y production indicated that CD4+ T cells are the major 
source of this cytokine, although stimulation with B. hyodysenteriae antigens decreased IFN-
y-producing CD4+ T cells. This effect was paralleled by an increase in yô T cells producing 
IFN-y. These results suggest that, as has been demonstrated for other infectious disease 
models, yô T cells may contribute to downregulate CD4+ T cell responses. A second study 
describes the impact that immunization and/or challenge had on the lymphocyte composition 
and cytokine environment of the colonic mucosa. Immunization decreased the colonic CD41" 
T cells irrespective of the challenge status, whereas challenge with B. hyodysenteriae resulted 
in depletion of epithelial yS T cells; although, vaccination ameliorated the loss of this 
vi 
lymphocyte subset. These cellular changes were accompanied by modulation of cytokine 
expression. Particularly, TNF-a, IL-1 (3 and TGF-3i mRNA were upregulated in vaccinated 
and infected pigs. The possible contribution of porcine CD4^ and yô T cells to the 
development and resolution of B. hyodysenteriae-induced colitis and the mechanisms of 
activation of the two subsets are discussed in this dissertation in the context of the present 
findings. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Brachyspira hyodysenteriae is a spirochete that causes swine dysentery, a severe 
mucohemorrhagic colitis (I). In addition to the etiologic agent, the presence of an appropriate 
intestinal flora is required in order for the disease to develop. This was shown in experiments 
involving germ-free mice or pigs, in which disease developed only after coinfection with 
Bacteroides vulgatus and B. hyodysenteriae (1 ; 2).The molecular pathogenesis of swine 
dysentery has not been elucidated; however, it is believed that colonization of the mucosa by 
B. hyodysenteriae results in the loss of the epithelial barrier function. This is due in to the 
production by the spirochete of a ^-hemolysin that is cytotoxic for enterocytes (3). This 
initial phase is followed by the invasion of the mucosa by commensal bacteria from the 
colon. Excessive exposure of the underlying mucosa to luminal antigens ultimately leads to a 
severe, acute inflammatory response (3; 4), which was characterized in a murine model o the 
disease by the upregulation of proinflammatory cytokines, such as tumor necrosis factor-
ex (TNF-a), interleukin I-(3 (IL-1(3) (5). Figure 1 depicts the most characteristic histologic 
features of the disease: superficial epithelial erosion, increased thickness of the mucosa with 
crypt hyperplasia, and leukocyte infiltration. The disease is basically restricted to the mucosa, 
although multifocal leukocytic infiltrates may sometimes be present at the submucosa (6). 
Figure 1: Photomicrographs of hematoxilin-eosin stained sections of porcine colon from a 
healthy (A) and a B. hyodysenteriae infected (B) pig at 160 x magnification. The most 
characteristic histopathologic features of the disease are increased thickness of the epithelium 
(indicated by arrows) with crypt hyperplasia, superficial epithelial erosions (indicated by an 
asterisk) and leukocytic infiltration. 
Systemic immunization with a B. hyodysenteriae protease-digested bacterin provides 
protection against the disease (i.e., reduced clinical signs), although it does not prevent 
bacterial colonization (7; 8). The vaccine has also been used as a tool for evaluating porcine 
T cell responses to extracellular bacterial antigens (8-12). A diagram showing the phenotypic 
classification of porcine T cells is depicted in figure 2. Based on T cell receptor (TCR) 
expression, porcine T cells can be divided into afi or yô T cells. aP T cells can be further 
subdivided depending on CD4 and CD8 coreceptor expression. Besides the CD4"1" CD8" aP T 
cells, three subsets of porcine CD8+ TCR aP T cells have been described: 1) CD4 CD8 
(%P or cytotoxic T lymphocytes, 2) CD4+ CD8acT or memory/effector T cells, and 3) CD4" 
CD8acT T cells, of unknown function (13-19). Finally, two major subsets of y5 T cells have 
been characterized: 1) SWC6^ CD2", which constitute the majority of the peripheral blood 
yô T cells, and 2) SWC6*CD2+ which are low in peripheral blood and preferentially migrate 
to non-lymphoid organs and spleen. A fraction of the SWC6~CD2+ y5 T cells also express 
CD8a (20-22). 
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Porcine T-lymphocytes 
a0 T cells yS T cells 
SWC6+ CD2-CD4+CD8- CD4+ CD8aa+ 
SWC6- CD2+CD8aa+ 
Figure 2: Subset classification of porcine T lymphocytes 
Previous studies reported that there was an increase in the percentage of CD8cf 
lymphocytes in peripheral blood, colonic lymph nodes (CLN), and colonic mucosa following 
challenge of vaccinated pigs with B. hyodysenteriae (10). Also, in vitro stimulation of 
peripheral blood mononuclear cells (PBMC) isolated from immunized animals resulted in 
antigen-dependent proliferation of CD8cf lymphocytes, CD4+ CDSacf, CD4+ CD8aa+, and 
TCR yô cell subsets. Blockade of antigen presentation with antibodies against class II major 
histocompatibility complex (MHC-II) diminished in vitro proliferation of PBMC from 
immunized pigs, and similar results were obtained by depleting CD4+ T cells (9). Therefore, 
vaccination with a B. hyodysenteriae bacterin induces a MHC-II-dependent CD41" T cell 
response. However, because significant proliferative responses of yô T cell are also induced 
following in vitro antigenic stimulation of unfractionated PBMC, this immunization regime 
can be utilized for the study of the differential mechanisms of activation of CD4+ and yô T 
cells. 
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The identification of yô T cells is relatively recent compared to a|3 T lymphocytes 
(23). Although both aP and yô T cells have the capacity to specifically recognize antigens 
through their respective TCR, the type of antigens recognized and the process of antigen 
recognition are different between the two subsets (23). In fact, knowledge on yS T cell 
biology has greatly increased in recent years, making it evident that their function in the 
immune system is different from that of ap T cells (23). The tissue distribution pattern of 
aP and yô T cells is a first indicator of their differential role. In mice and humans, y5 T cells 
are almost absent from peripheral blood and organized lymphoid tissues. In other species 
such as poultry, cattle or pigs, yô T cells constitute a major proportion of the pool of 
circulating lymphocytes, and they are present in secondary lymphoid organs although in low 
numbers (24-26). In both cases, yS T cells are abundant at mucosal sites (27). On the other 
hand, the T cell population within the spleen and lymph nodes are predominantly aP T cells. 
These are the compartments of the immune system where naïve T cells are first exposed to 
antigens processed and presented by professional antigen presenting cells (APC) and after 
antigen presentation, naïve T cells undergo clonal expansion and differentiation into 
effector/memory cells (28). Because yS T cells are not retained at these sites, it could be 
predicted that their involvement in the immune response is different from that of ap T cells. 
Questions relating to the process of antigen presentation to yÔ T cells (e.g., MHC-restriction, 
requirements for APC or costimulation) and whether or not they become memory cells are 
currently under investigation (27). 
yô and CD41" T cells are the two T cell subsets responding following immunization 
with a B. hyodysenteriae bacterin (10). During the clinical period of swine dysentery, the 
bacteria invade the colonic mucosa without spreading systemically (6). Thus, by utilizing 
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different routes of antigenic exposure, this model offers the possibility of evaluating the local 
response of CD4+ and y5 T cells at the colonic mucosa (i.e., following challenge), 
systemically (i.e., by intramuscular immunization), or as a result of the interaction between 
immunization and challenge. 
Objectives of the dissertation 
The objectives of the experiments conducted for this dissertation were to evaluate the 
impact that immunization and /or challenge with B. hyodysenteriae had on porcine CD4~ and 
yS T cells. More specifically, we investigated in vitro differential aspects of the responses 
(i.e.. proliferation and cytokine production) of CD4+ and yS PBMC to B. hyodysenteriae 
antigens following immunization. At the colonic mucosal level, we examined the changes 
that immunization and/or challenge induced on the numbers and distribution of these subsets 
at the colonic mucosa. 
Dissertation organization 
This dissertation is organized in four chapters: a General Introduction (chapter 1), two 
journal style manuscripts (chapters 2 and 3) and a General Conclusion (chapter 4). 
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LITERATURE REVIEW 
Functional differences between af) and y8 T cells 
T cells derive from pluripotent precursors that follow the lymphoid lineage of 
differentiation (29; 30). Their designation as "T cells" comes from their "thymus-dependent" 
origin. Although this terminology has been maintained, the existence of extrathymically-
derived T lymphocytes has been known for a long time (31-33). By definition, all T cells are 
lymphocytes that in mature state express a T cell receptor (TCR) (28). The TCR is a 
heterodimeric molecule that results from the association of a and P (TCRaP), or y and 
5 (TCRyô) polypeptide chains. Thus, two major subsets of T cells exist based on the type of 
TCR expressed on the cell surface: (%P and yô T cells (34). Concepts related to T cell biology, 
such as MHC restriction, immunological memory or acquired immunity resulted from studies 
on «P T cells. yS T cells were identified more recently than aP T cells, and initial studies 
demonstrated that some principles of aP T cell biology would not apply to them. There is 
enough evidence now to support that, rather than being exceptions, y8 T cells have different 
and non-overlapping roles in comparison to (%P T cells within the immune system (23; 35). 
Origin and tissue distribution of C# and yS T cells 
Although both cell types originate from a common lymphoid precursor, they diverge 
early in ontogeny (36). During lymphocyte development, thymocytes commit to either the 
aP or yô T cell lineage. Thymocytes that successfully rearrange a TCR, either aP or yS, 
become naïve mature T cells (30). A difference between aP and y8 T cell development is that 
y8 T cells are considered mature lymphocytes from the moment they express a functional 
TCR (30; 37). At this point, they migrate to the periphery (27). Conversely, thymocytes that 
have committed to the aP T cell lineage go through several checkpoints before becoming 
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mature cells. The first checkpoint occurs during the process known as |3 selection (i.e., in-
frame rearrangement and successful expression of the TCRP chain) (38), afterwards, a(3 TCR 
thymocytes capable of recognizing self-MHC through the rearranged TCR are rescued from 
apoptosis or are positively selected (39). Finally, the recognition of self-peptides through the 
TCR generates strong signals that activate apoptosis. This phenomenon, known as negative 
selection, prevents auto-reactive T cells from migrating to the periphery (40; 41). 
A second aspect that differentiates a(3 and yÔ T cells is their trafficking patterns. 
Naïve a(3 T cells migrate from the thymus to secondary lymphoid organs where, eventually, 
they will be exposed to antigen and differentiate into effector or memory 
cells. Effector/memory a(3 T cells then home to non-lymphoid tissues where they sample for 
their cognate antigen. In contrast, yô T cells directly accumulate in non-lymphoid tissues, 
especially at mucosae, without the need of a previous antigenic exposure (27; 42; 43). Most 
challenges to the immune system of environmental origin, (e.g., infectious agents or 
allergens), occur at mucosal sites. While yô T cells are ready to respond to an antigenic 
challenge, aP T cells must have been previously exposed to the antigen in a secondary 
lymphoid organ. Because this process requires some time for aP T cells, it has been proposed 
that yô T cells constitute a first line of defense (44). 
Differential aspects of antigen recognition between af) and y6 T cells 
Antigen presentation to naïve aP T cells is a function of dendritic cells (DC) that 
have migrated from the periphery to secondary lymphoid tissues (45). Because yô T cells are 
not retained at these sites, the question then is how does antigen presentation to yô T cells 
occur? aP T cells recognize peptides resulting from antigenic processing, presented in 
association with MHC-class I or II molecules on the surface of target cells or APC to CD8+ 
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(i.e., cytotoxic) or CD4+ (helper) T cells (28). The yô TCR is MHC-I and II-unrestricted; 
instead, non-classical MHC molecules, namely T10/T22(46), its murine homologue retinoic 
acid early inducible Rae (47) antigen or CD I (48) are ligands for the yô TCR. In addition, 
previous research showed that inhibition of antigen processing and presentation by classical 
MHC molecules did not affect y5 TCR activation (46). These results lead to the conclusion 
that yô T cells recognize unprocessed antigens. However, in similar action to a(3 T cells, cell 
to cell interaction and costimulation are required for yô T cell activation through the TCR 
(49). Therefore, yô T cells are capable of recognizing unprocessed antigens directly on 
tissues without the mediation of a professional APC (27). 
MHC-I and II molecules are specialized in presenting peptidic epitopes to T cells 
(50). In addition to recognizing protein-derived antigens (e.g.,glycoprotein 1 from Herpes 
simplex virus) (51), yô T cells recognize non-peptidic molecules. Special attention has been 
given to the capacity of phosphoantigens, low molecular mass molecules rich in phosphate 
groups abundant in bacteria (e.g., Mycobacterium spp, Escherichia coli), to stimulate human 
yÔ T cells (52-55). In addition, it has been shown that yÔ T cells can recognize stress-induced 
self-molecules such as MHC-class I related chain A (MICA) (56), its murine homologue 
retinoic acid early inducible Rae (47) antigen (56), and transformed cells (57). 
Comparison and contrast between the a0 and the y8 TCR 
Structure of the TCR 
Studies on the structure of the TCR have provided a basis for some of the differences 
between a(3 and yô of T cells. As already mentioned, the TCR is a heterodimer formed by 
two disulphide-linked polypeptide chains; a-fi or y-ô . It is always expressed along with the 
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CDS complex, thus phenotypically, T cells are designated as CD3+. The CD3 complex is the 
association of three different polypeptide chains (i.e., CD3y, CD3S and CD3e), with an 
extracellular immunoglobulin-like (Ig-like) domain and a short cytoplasmic tail. Also, most 
of the TCR-CD3 complexes are associated with a homodimer formed by two Ç chains, or a 
heterodimer formed by Ç and its alternative spliced form, x\. The latter proteins have a very 
short extracellular domain and a long cytoplasmic tail that very actively participate in TCR 
signal transduction (58). The composition of the TCR complex is not constant and varies 
depending on developmental or activation state of the cell (28; 59; 60). 
Based on genetic features and protein structure, the TCR has been classified within 
the immunoglobulin superfamily. Figure 3 depicts the structure of a TCR. Each polypeptide 
chain results from the combination of one invariant, or constant (C) (i.e., Ca and CP in the 
TCRaP, or Cy and CÔ in the TCRyô), and one variable (V) region (i.e., Va and VP or Vy 
and Vô) (28; 30; 61-63). The C portion of the protein has an Ig-like domain followed by a 
hinge region, a transmembrane region and a short cytoplasmic tail. Cystein residues at the 
hinge region are involved in dimer formation between a and P or y and Ô chains. The 
transmembrane domain facilitates the association between the TCR and the CD3 signaling 
complex. In the case of antibodies, different isoforms exist for the C region (i.e., isotypes). In 
contrast, isotypic variation at the TCR C region is lower (28). Two isoforms of the Cp genes 
have been described in the mouse with apparently no significant functional differences (64) 
and three isoforms of the Cy have been identified in the pig (65). 
The variable domain of the TCR results from the somatic recombination of germline 
encoded gene segments (29). The great advantage that this unique system shared by the TCR, 
B cell receptor (BCR) and antibodies, is the generation of receptor diversity. This allows for 
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the specific recognition of the great variety of antigens to which the immune system is 
exposed. TCR diversity is achieved by recombination of different segments that will form the 
V chain. The a and y V chains result from the recombination of V and joining (J) segments, 
(i.e., VJ). In the P and S chains, an additional diversity (D) segment is incorporated into the V 
chain (i.e., VDJ). The existence of several V, D and J genes that can be recombined in the V 
chain is what brings about receptor diversity (66). 
Amino acid sequence comparisons of V domains of each of the polypeptide chains 
that form the TCR indicated that within the V chain there are regions of hypervariability 
(HV) (67). The HV regions of the a-P or y-S chains form the complementary determining 
regions (COR) on the TCR. The CDR1 and CDR2 domains interact with MHC-I or II for aP 
T cells, or a non-classical MHC molecule in the case of yô T cells. The CDR3 is the region of 
the TCR that is directly implicated in antigen recognition (68; 69). This feature is indicated in 
figure 3. 
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Structural differences between the C 
regions of the aP and yô TCR 
suggest that the two types of 
receptors form different signaling 
complexes. 
CDR3 has the same length in Va and 
Vp, but it is longer in Vô than in Vy. 
This feature is also present in antibody 
molecules. From this finding it was 
interpreted that yô T cells recognize 
epitopes in a similar fashion to 
immunoglobulins. 
Figure 3. Crystal structure of an aP T cell receptor (TCR) interacting with a major 
histocompatibility complex (MHC-l) molecule loaded with a peptide (P1-P8). The 
complementary determining regions (CDR) are the loops represented in colors at the are area 
of contact between the TCR and the MHC-peptide complex. The major structural differences 
between the ap and the yô TCR, and the functional implications that they have are indicated 
in boxes (with permission from LA, Wilson) (70). 
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Differences Between the (*P and y5 TCR 
Comparative studies examining the structure and function of the a(3 and yô TCR 
showed that the CDR3 of VS is longer than the CDR3 of Vy (70). This structural feature 
results from the rearrangement of up to three D segments and the addition of N-nucleotides 
in VÔ (71). In contrast to this, the CDR3 of the a and p chains are of the same length (70). 
Besides, the number of amino acid residues that form the CDR3 is larger in the yô than in the 
aP TCR. These structural differences have important functional implications (70). T cells 
recognize peptides of 6 to 12 aminoacids in length that result from antigen processing and are 
presented by MHC molecules on APC (28). In turn, yô T cells can recognize antigens of 
different chemical structure other than proteins (e.g., phosphoantigens or lipoproteins) (52-
55; 72; 73). In fact, based on the basis of the CDR3, the yÔ TCR closely resembles 
antibodies, which have longer CDR3 in the heavy than in the light chain (70). These 
structural similarities between immunoglobulins and the yôTCR suggest that yÔ T cells can 
recognize unprocessed antigens (46; 74-76). However, in contrast to antibodies, antigen 
recognition by yô TCR requires cell to cell contact (49). 
The first crystallographic model of a complete human yô TCR (i.e., Vy9 VÔ2) was 
recently published (63). Vy9 VÔ2 T cells constitute the majority of the circulating y5 T cells 
in humans (77-79). In this specific case, the CDR3 regions are of the same length in the y and 
Ô chains. The most significant differences with the aP TCR are found in the C chain. The 
comparison of both the structure and shape of the «P and yô TCR reveals that they form 
different signaling complexes. First, within the C chain Ig-like domain, the polypeptide 
domain that in the «P TCR apparently associates with the CD3E (i.e., FG loop), is longer 
than the corresponding region in the yô TCR. In addition, both receptors differ in their hinge 
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regions, with a maximum of 7 versus 23 residues between the end of the Ig-like domain and 
the interchain disulphide bond in the ap and yÔ TCR, respectively. These particularities 
indicate that a different type of association exists between the CD3 complex and the a(3 or 
yS TCR and that the receptor on yS T cells has higher flexibility (63). As already mentioned, 
three Cy isoforms have been described in the pig (65; 80). It is interesting that the three 
isoforms are different from one another in the hinge region and in the cytoplasmic tail. 
Again, these differences suggest that yô T cells form different signaling complexes and, 
therefore, distinct signal transduction pathways may regulate activation of the different yô T 
cell subsets. 
In summary, both the a(3 and the yô TCR belong to the immunoglobulin superfamily, 
however, modifications of the C and V domains account for their differential biological 
properties. Mainly, the type of antigen that they recognize, the mechanisms of antigen 
recognition, and the association with signaling complexes are characteristic for each receptor. 
The overall result is that the two cell types have different roles within the immune system. 
Porcine aP CD4 T cells 
An important role of the CD4+ T cells is to coordinate acquired immune responses. 
They are involved in both cellular and humoral responses by serving as intermediates 
between antigen presenting cells (APC) and B cells, for the production of antibodies, or 
cytotoxic T cells (28). T helper 1 (Thl) and Th2 cells regulate immune responses involved in 
the elimination of foreign antigens of microbial origin (81). CD4+ T cells are implicated in 
the discrimination of self from non-self are equally important. In this regard, CD4+ 
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regulatory T cells control other lymphocytes capable of recognizing self-antigens preventing 
autoimmune diseases (82). 
CD4 is a glycoprotein that possesses 4 Ig-like domains. It interacts with a non-
polymorphic region on the (32 domain of the MHC-II molecule stabilizing antigen 
recognition by the TCR. In addition, its cytoplasmic tail associates with Lck, a tyrosine 
kinase of the Src family that participates in proximal signal transduction events (83-85). 
Although no monoclonal antibodies that recognize the a or p chains of the porcine TCR are 
available, CD4+ T cells are CD3+ and are considered TCRaP cells (14; 86; 87). The Thl/Th2 
paradigm has not been demonstrated for porcine T cells. However, it is assumed that porcine 
CD4+ T cells have similar roles to CD4T T cells from other species, and that they use the 
similar effector mechanisms (87; 88). CD4 T cells provide help for the generation of 
alloantigen-specific responses (89). The expression of MHC-II antigens is unique to a subset 
of porcine CD4+ T cells (i.e., CD44" CD8acO- Although the significance is unknown, it 
seems that it does not confer them with the ability to present antigens, because the absence of 
other accessory APC abrogated alloantigen-specific responses (89). It has also been 
suggested that CD4"1* T cells interact with B-cells for the generation of humoral responses 
(90). 
Most of the information currently available with regards to the biology of porcine 
CD4+ T cells has been obtained in the context of the cellular immune responses to infectious 
agents, mainly of viral origin. As it can be expected, infections of bacterial, viral or parasitic 
etiology induce detectable in vivo changes in the CD4+ subset (91-96). In vitro, CD4+T cells 
proliferate in response to viral or bacterial antigens and these antigen-specific responses are 
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MHC-II restricted (9; 88; 97). In addition, CD4+ T cells become CD8aa+ during antigen-
specific recall responses (18). 
Coexpression of CD8aa in mature porcine CD4 T cells 
The simultaneous expression of the CD8aa coreceptor on peripheral mature CD4+T 
cells has been emphasized as one of the distinctive characteristics of the porcine immune 
system. However, other species have also detectable numbers of CD4+ CD8aa+ T cells (e.g., 
monkeys and chickens) (17). The CD8 molecule is coexpressed on mature CD4+ T cells in 
low levels and always as a CD8aa homodimer, which differentiates it from the CD8«P 
heterodimer on CD8+ cytotoxic T cells (9; 14; 98). CD4+CD8aa+T cells are normal 
components of the gut mucosa (99). In healthy individuals conditions, a small percentage of 
peripheral lymphocytes are CD4+CD8aa+T cells. However, the presence of this subset is 
associated with certain diseases such as neoplasia (100) or rheumathoid arthritis (99). 
It is has been accepted that porcine CD4^CD8acTT cells represent a fraction of 
memory/activated cells within the CD4"1" pool (18). This assumption is based on the lack of 
expression of CD1 (101), a molecule present on immature T cells, and the fact that the 
numbers of CD4 CD8aa T cells increase with age, suggesting that this is the result of 
antigenic exposure (17; 18). Ontogenetically CD4+CD8aa+T lymphocytes are undetectable 
until day 90 of gestation. The peripheral blood of newborn piglets posses approximately I % 
of CD4+CD8aa+T cells (102). This number increases to 30-55 % of the total PBMC in 3 
year old pigs (18). 
In vitro experiments showed that sorted CD4+ T cells from pigs immunized against 
pseudorabies virus (PRV) became CD8acT after ex vivo stimulation with PRV antigens (18). 
Moreover, most of the CD4 CDScxct T cells also coexpressed CD29, a phenotypic marker of 
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memory T cells (18). Neither the mechanisms regulating CD8aa expression on porcine T 
cells, nor its functional role on these cells have been investigated to date. 
The CDS coreceptor: isoforms, function and regulation of cell surface expression 
CD8 is a glycoprotein of the immunoglobulin superfamily. There are two isoforms: 
CD8a and CD8P; the association of two a chains or an a and a P chain form the 
homodimeric or heterodimeric forms of the coreceptor, respectively (103; 104). The CD8aP 
form is characteristically expressed on cytotoxic T cells (104; 105), while CDSaa can be 
expressed on dendritic cells (106), natural killer cells, yô T cells and on mature CD4T T cells 
(107). The CD8 coreceptor facilitates the interaction with APC. Both forms of the coreceptor 
recognize non-variable regions on the MHC-l molecule (108) and, in addition, CDSaa 
recognizes non-classical MHC antigens as has been reported for thymus leukemia (TL) 
antigens expressed by enterocytes ( 109). 
There has been some controversy regarding which form of CDS is more efficient as a 
coreceptor. Soluble CDSaa and CDSaP molecules have equal binding affinity for MHC-I 
(110), however, cell-associated CDSaP is more efficient coreceptor than CDSaa (111). The 
clearest difference between the coreceptors is in their contribution to T cell activation. CDSa 
has a long cytoplasmic tail that associates with Lck (85). As it has been indicated for the CD4 
coreceptor, this interaction is important in early signal transduction events mediated by the 
TCR. CD8P has a short cytoplasmic tail and does not associate with Lck (112); however, it 
has a domain that is necessary for palmitoylation and for the recruitment of CDSaP into lipid 
rafts, where most of the cellular Lck is found (113). Deletion of the palmitoylation residue on 
CDSP abrogated its ability to partition into lipid rafts, and chemical inhibition of 
palmitoylation decreased T cell activation (114; 115). Thus, CDSP is crucial role for the 
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formation of efficient signaling complexes and activation of cytotoxic lymphocytes through 
the TCR. On the other hand, although CD8aa can associate with Lck, the lack of a 
palmitoylation residue suggests that it cannot come in contact with the TCR, and therefore, it 
does not participate in T cell activation in the same way that CD8«P would (115). 
In the mouse, the genes that code for CD8a and CD8(3 are in close proximity on 
chromosome 6(116). Both transcriptional and postranscriptional mechanisms for the control 
of the expression of these genes have been described. Within the transcriptional mechanisms, 
there are four enhancers (E8t-E8iv) that are tissue-, lineage-, and developmentally-specific 
(117; 118). For instance, E8, regulates CD8a expression in T cells and mature single positive 
(SP) thymocytes, but it has no effect in double positive (DP) thymocytes. Also, it controls the 
expression of CD8a in NK cells, intestinal TCRyô CD8aa and TCRaP CD8aa T cells but 
not in TCRaP CD8a|3 intraepithelial lymphocytes (IEL) (118-120). Neither CD8a nor 
CD8P genes of the pig have been sequenced, and no information is available on how its 
expression is regulated. It could be anticipated that an element similar to E8, exists which 
regulates the expression of porcine CD8a gene, because the homodimeric form of CD8a is 
expressed in equivalent cell subsets. With regards to postranscriptional regulation, mature 
human CD4+ T cells transcribe CD8a, although the mRNA is very unstable and the protein is 
never produced (121). However, it was reported that phorbol myristate acetate (PMA)-
activated human CD4+ T cell clones were able to synthesize and coexpress CD8a in the 
presence of interleukin-4 (IL-4). The synthesis of CD8a was transient and downregulated by 
IL-2 (122). Although these are in vitro studies, certain human diseases such as neoplasia 
(100) or rheumathoid arthritis (99) are associated with an increase in recirculating mature 
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CD4+CD8TT cells. Therefore, molecular mechanisms that stabilize CD8a mRNA could 
enhance the expression of CD8a on the surface of CD4+ T cell. 
Possible explanations for the function of mature CD4+CD8aa+T cells 
A question that remains to be answered is what are the functional differences between 
CD4""T cells and CD4+CD8acf T cells. It has been hypothesized that human CD4+CD8acT 
are regulatory cells. Consistent with this hypothesis, cloned CD4+CD8+aaT cells from 
lepromatous leprosy patients inhibited activated T cells (124). In line with the findings in 
human lymphocytes, porcine CD4TCD8+aaT cells isolated from peripheral blood were 
shown to express high levels of IL-10 mRNA (92). IL-IO is a cytokine associated with 
regulatory responses (125; 126). However, a different study showed that peripheral blood 
CD4^CD8aa*T cells produced high levels of IFN-y when stimulated with PMA and 
ionomycin (127). 
A second theory proposes that circulating human CD4TCD81aaT cells have 
cytotoxic activity. In support to this theory, addition of anti-CD8a monoclonal antibodies 
blocked anti-CD3-induced cytotoxicity of human CD4+CD8+aaclones (123). Porcine CD4T 
CD8+aaT cells isolated from PRV-immunized pigs contributed to MHC-class [-restricted, 
antigen-specific cytotoxic activity of CTLs (128). It has also been suggested that porcine 
CD4+CD8+aaT cells could themselves be cytotoxic (129). It is improbable that the 
mechanism of cytotoxicity depends on dual MHC-I/MHC-II restriction of CD4+CD8aoTT 
cells, because the CD4+ T cell precursors express a TCR specific for a MHC-II-dependent 
epitope. Although this rules out the dual MHC-I/MHC-II-restriction of porcine CD41" 
CD8aa+T cells, they could still induce cytotoxicity of target cells by alternative mechanisms 
(e.g., Fas-FasL interaction). This hypothesis, however, has not been tested. Studies on the 
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localization of CD8aa on the cell membrane of CD4+CD8aa+T cells and the determination 
of the molecules that associate with the cytoplasmic tail would help in elucidating if 
CD8aa contributes to TCR-mediated activation of CD4+T cells. In addition, the 
identification of the factors that stimulate CD8aa expression would provide some insights 
into the possible role of porcine CD4+CD8aa+T cells as memory/effector T cells. 
Porcine yfi T cells 
yô T cells were discovered during the identification and sequencing of the 
genes for the a and (3 chains of the TCR (130-132). One of the principal characteristics of y5 
T cells is that they tend to accumulate in non-organized lymphoid tissues, especially the skin 
and intestinal mucosa (27). However, species-specific differences have been reported, with 
mice and humans having very low numbers of circulating yô T cells while in pigs, ruminants 
and chickens they constitute an important fraction of the PBMC (24-26). When monoclonal 
antibodies became available for some of the cell surface markers of porcine lymphocytes, it 
was observed that a high proportion of PBMC were negative for either B or T cell surface-
expressed proteins (i.e., CD4, CD8 or slgM). These "non-B, non-T cells" were subsequently 
phenotypically characterized as y8 T lymphocytes (133). 
The classification of mouse and human yô T cells is based on their variable TCR gene 
usage (35) while the pig it is based on their phenotypic characteristics. There are two main 
subsets of porcine y5 T cells. One is the analogue of bovine WCl^yô T cells and is 
phenoty pically defined by the expression of SWC6 and CC101 antigens. Bovine WC1 is a 
member of the scavenger receptor cysteine-rich family and, antibodies against CC101 
recognize a related molecule expressed by pig yô T cells. This subset is also CD2~ and CD8a. 
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SWC61" TCRyô cells constitute the majority of the yô T cells in PBMC (26; 134). The second 
subset can be phenotypically defined as SWC6" CD2+, of which a small fraction expresses 
CD8a. Cells from this subset have been detected in the spleen and lymph nodes and as 
recirculating lymphocytes (134; 135). 
Protein analyses of the yS TCR yield a unique form of the 8 chain of 38 kDa, and 3 
isoforms of the y chain of 37, 38 and 46 kDa. The 37 and 38 kDa isoforms are expressed in 
CD2CD8" (i.e., SWC6*) y5 T cells. These two y chains are subset-specific, as the 38 kDa 
iso form is only present in circulating SWC6+ cells that also express the 86D molecule, while 
the 37 kDa form is characteristic of circulating but also tissue-resident cells. Finally, the 46 
kDa iso form was attributed to CD21" CD8*(SWC6") cells present in secondary lymphoid 
tissues (81). Cloning of the porcine Cy chain revealed the existence of 3 iso forms different in 
their hinge regions. Two of them (G10 and G15) are similar to each other with longer hinge 
regions that have 2 additional cysteine residues in comparison with the G4 isoform. The third 
iso form (04) differs from G10 and G15 in its shorter hinge region and in the cytoplasmic 
tail. G10 and G15 were identified as the 37 and 38 kDa isoforms of the y chain. The 46 kDa 
isoform, however, has not been matched to any Cy sequence (65). A possible explanation for 
this is that PBMC were used as a source of T cells for cloning the Cy, when cells bearing the 
46 kDa chain are found in lymphoid tissue. 
Very little information is available regarding functional aspects of porcine y5 T cells. 
There are reports describing yô T cells from peripheral blood proliferating in vitro to viral or 
bacterial antigens (9-11; 89; 98). However, they appear to have very low capacity of IFN-y 
production in vitro (127). Porcine CD6* lymphocytes are functionally characterized by having 
non-specific cytotoxic activity (128). The SWC6+ subset of porcine yS T cell is CD6 
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and has NK-like activity (127; 135). In addition, it was shown that this cell type 
preferentially migrated to sites of cutaneous inflammation induced by administration of 
phytohemagglutinin (136; 137). There are contradictory results with regard to the SWC6" 
yÔ T cells. They have been described as both CD6" (I28)and CD6+ (133) by different authors. 
Thus, their function remains unclear. 
Lymphocyte composition of the intestinal mucosa 
The intestinal mucosa is the most inner layer of the gut wall. It is divided in two 
functional and structurally different compartments: lamina propria and epithelium. The 
intestinal epithelium is a single cell layer of polarized cells exposed to the lumen, thus, in 
direct contact with the intestinal contents (138). Lymphocytes constitute an important portion 
of both the lamina propria (i.e., lamina propria lymphocytes, LPL) and the epithelium (i.e., 
intraepithelial lymphocyes, IEL) (139; 140). However, the lymphocyte composition of the 
mucosa is not random, but characteristic of the different anatomical regions of the intestine 
(e.g., small versus large intestine), and of each of the two compartments (i.e., epithelium 
versus lamina propria) (141; 142). In addition, due to the specific functions that the immune 
system has at this site, lymphocytes from the intestine are different in several aspects (138). 
In regards to the phenotype, they have an atypical pattern of expression of cell surface 
molecules compared to conventional lymphocytes at the systemic/central lymphoid system. 
First of all, the gut associated lymphoid tissue (GALT) is rich in y5 T cells (143) and, within 
the aP T cell fraction, cells expressing CD4 (TCRaP CD4+CD8"), CD8 (TCRaP CD4* 
CD84), or neither of the coreceptors (TCRaP CD4~CD8~) have been described (139; 144). In 
addition, the expression of the CD8aa homodimer is common among cells of both the aP 
and yô T cell lineage (145; 146). In the mouse, it has been proven that the CD8aa I EL 
develop extrathymically while the rest are of thymic origin and migrate from the periphery to 
colonize the intestine (147; 148). This separation in origin has not been elucidated in other 
species 
Lymphocytes of the epithelium and lamina propria constitute the diffuse lymphoid 
tissue of the GALT as opposed to isolated follicles, Peyer's patches, lymphocyte-filled villi 
and cryptopatches, which constitute the organized lymphoid tissue (140; 149). Functionally, 
diffuse and oganized lymphoid structures are effector and inductor sites, respectively (140). 
In the porcine small intestine, the crypt areas of the lamina propria are rich in plasma cells 
while T cells, most them ofCD4+ phenotype although there are also some CD8T, localize 
within the villi. The CD4+ cells are in close association with the epithelium, as they are 
located right underneath the basement membrane (150). The IEL constitute approximately 20 
percent of the epithelial cells and are distributed mainly in the villus. In a recent study, it was 
reported that in adult pigs approximately 50 % of the IEL were CD2+ CD4" CD8+ and were 
localized in the proximity of the basement membrane. The remaining, CD2+ CD4" CD8" IEL, 
were aligned with the enterocyte nucleus except for a small percentage located towards the 
apical side (151). This study did not include additional markers, therefore, it cannot be 
concluded to which T cell lineage (i.e.,oc(3 oryÔ) these cells belong. When the lymphocyte 
composition of the intestinal mucosa was first evaluated, monoclonal antibodies to the 
yd TCR were not available yet. For this reason the classification has been incomplete until 
recently. yS T cells have been found in both epithelium and lamina propria (152). Currently, 
there are no publications describing the lymphocyte composition of the large intestine of the 
pig. Immunohistochemical analyses done in our laboratory have shown similar distribution of 
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CD4\ CDS and y§ cells in the colon: CD4+ cells are only present as LPL and, CD8T and 
TCRyS localize to both compartments (unpublished data). However, the exact percentages of 
and numerical evaluation of each cell type has not been completed yet. 
Role of T cells in the development and regulation of intestinal inflammation 
Cellular mechanisms involved in intestinal mucosa homeostasis 
Cells of the systemic/central immune system are constrained within a sterile 
environment and will react to any antigen recognized as non-self. However, the G ALT has 
evolved to be in a non-sterile environment, under constant antigenic challenge. Several 
mechanisms operate for maintaining tolerance towards antigens from food origin and from 
the enteric normal flora. At the same time, the G ALT has to keep its capacity to react to 
pathogenic microorganisms (144). Thus, establishment of equilibrium between active 
responses and tolerance ensures the maintenance of the barrier function across the mucosa 
(153). 
Anergy, or lack of reactivity, is one of the mechanisms by which tolerance towards 
food antigens or intestine-associated commensal flora is maintained (144). Several theories 
have been proposed to explain how anergy is established. It has been hypothesized that 
antigen presentation in the absence "danger signals" leads to anergy (154; 155). Such signals 
originate from bacterial products referred to as pathogen-associated molecular patterns 
(PAMPs) (e.g., lipopolysaccharide or peptidoglycan) which are specifically recognized by 
pattern recognition receptors (PRR), such as toll-like receptors (TLR) on the surface of APC 
(156; 157). Signaling through TLR results in the surface upregulation of costimulatory 
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molecules thus, in the absence of PAMPs, APC will not provide sufficient costimulation, 
which will result in incomplete T cell activation, or even apoptosis (i.e., clonal deletion). 
The route of antigenic exposure is an important parameter that contributes to the 
maintenance of tolerance. In normal conditions, antigens from the intestinal lumen are 
sampled through M-cells (i.e., at the small intestine), or through the apical side of the 
absorptive epithelium (138; 140). Enterocytes are polarized cells (i.e., their plasma 
membrane is divided into domains with different properties). TLR are expressed by 
absorptive enterocytes, but only at the basolateral side (158). Tight junctions prevent 
paracellular transport across the epithelium (159-161), therefore, this physical separation 
between luminal contents and the basolateral side of enterocytes blocks recognition of 
bacterial products by TLR or other PRR. However, whenever the integrity of the intestinal 
epitheluim is compromised, the basolateral side of the enterocyte will be exposed to luminal 
bacteria, which will ultimately lead to an inflammatory response (162; 163). 
Several experimental models have been developed for the study of intestinal 
inflammation (153; 164). Irrespective of the etiopathogenesis for each model, a common 
denominator is that inflammation results from a break in tolerance and/or an imbalance in the 
production of molecules that maintain intestinal homeostasis (153). Cellular interactions at 
the intestinal mucosa are extremely complex, however, because of the focus of this 
dissertation, only CD4+and yÔT cell involvement in the development and regulation of 
intestinal inflammation will be discussed below. 
Role of CD4 in the establishment and resolution of inflammation 
CD4+T cells have been implicated both in the development of colitis and in the 
maintenance of tolerance. Following antigen presentation to naïve CD4+T cells, they 
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differentiate into either Thl or Th2 effector cells (165; 166). The Thl phenotype is 
associated with cellular responses modulated by proinflammatory cytokines, mainly IFN-y 
and DC-derived IL-12 (167; 168). On the other hand, Th2 polarized responses are 
characterized by the predominance of cytokines that favor humoral responses. Increased 
production of IL-4 or IL-5 is an indicator of an ongoing Th2 response (166). The Thl/Th2 
paradigm was first investigated in vitro using differentiated T cell clones. Usually, in vivo 
both Thl and Th2 cells are present and there is a reciprocal regulation between cells of each 
type (169). However, genetic and environmental factors may alter this equilibrium resulting 
in a biased Thl or Th2 effector response (170). 
Even though both polarized Thl and Th2 responses can be involved in the induction 
of intestinal inflammation, this pathology is more commonly associated with Thl than with 
Th2 responses (171). It has been speculated that the reason for this is that bacteria of the 
normal flora, which play a critical role in the pathogenesis of inflammation, trigger the 
production of IL-12 by DC, and therefore, the differentiation of naïve T cells into effector 
Thl cells (153; 172-174). In line with this mechanism of pathogenesis, the cellular 
mechanism underlying B. hyodysenteriae-induced colitis would be activation of intestinal 
resident DC by B. hyodysenteriae and members of the normal flora. These activated DC 
migrate to colonic lymph nodes, where they present antigens to naïve T cells in a 
microenvironment influenced by IL-12 that favors the differentiation of naïve T cells into 
Thl cells. Subsequently, bacterial-sensitized T cells would home to the colonic mucosa, 
establishing a predominant Thl profile. 
Cytokines produced in the context of a polarized Thl response, mainly IL-12 and. 
IFN-y, inhibit the development of Th2 cells (175; 176). It has been proposed that the absence 
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of an active Thl response favors the differentiation of Th2 cells (168), while IL-10 and TGF-
P, produced by T reg cells, inhibit the production of IL-12, and therefore the development of 
Thl cells (177; 178). During an inflammatory response driven by Thl cells, Th2 cells 
migrating into the mucosa could block the effects of activated Thl effector cells responding 
to members of the normal flora. This model could explain why vaccination with a B. 
hyodysenteriae bacterin protects against swine dysentery. Basically, whereas challenge 
would induce a Thl-type response, parenteral immunization would favor the development of 
Th2 effector cells. Following infection, Th2 cells could migrate either to the colonic lymph 
nodes and block the differentiation of naïve T cells into Thl cells, or directly to the mucosa 
and inhibit effector Thl cells. Studies in mice have shown that infection with B. 
hyodysenteriae increased IFN-y-producing cells in mesenteric lymph nodes and spleen, and 
favored immunoglobulin isotype switching to IgG2a, which is characteristic of a Thl 
response. However, cytokine analysis on vaccinated mice did not show increased production 
of IL-4, which would indicate a predominant Th2 response. The lack of IL-4 and increased 
production of IL-10 and TGF-(3 suggest that, alternatively, vaccination could stimulate 
regulatory T cells (T reg), rather than inducing a Th-2-type response (179). 
T reg cells have been identified in mice as memory CD4+ CD45RB10 cells that 
provided protection against colitis induced by naïve CD4* CD45RBhl cells, when both were 
transferred into a T cell-deficient SCID mouse (180). Functionally, T reg cells are 
characterized by the production of TGF-P and IL-10, but not IL-4 (181). Additionally, T reg 
cells have been shown to inhibit auto-reactive T cells, therefore, preventing autoimmunity 
(82; 182). It could be hypothesized that immunization with B. hyodysenteriae stimulates T 
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reg cells, which would block the effect of Thl cells reacting to antigens of the normal flora 
by producing TGF-P and IL-10. 
yS T cell involvement in the control of inflammation 
In regards to the involvement of yô T cells in intestinal inflammatory disorders, it 
appears that they do not have a crucial role in the development of inflammation (153). 
However, it has been suggested that they contribute to the process of epithelial restitution 
that follows severe inflammation (72; 183; 184) and to downregulation of inflammatory 
responses. Several models of infectious disease in which inflammation is present indicate 
that a(3 T cells are increased initially, whereas y5 T cells are elevated later in the course of 
the disease (185-188). The use of mice deficient in yô T cells indicated that they are 
specifically implicated in the resolution of inflammatory damage. For instance, lesions 
associated with infection with Listeria monocytogenes were more persistent in mice depleted 
ofyô T cells (189; 190). It has been reported that during L. monocytogenes infection, yÔ T 
cells shut down inflammation by inducing apoptosis of activated macrophages (191). 
Another observation of these studies is that yô T cell responses are not specific for the 
microorganism causing the disease (185). The fact that a subset of murine intraepithelial, 
skin resident, yô T cells, (i.e., dendritic epidermal T cells (DETC)), were activated in vitro by 
transformed or injured, but not healthy keratinocytes, suggested that stress-induced antigens, 
rather that bacterial products might activate yô T cells (192; 193). 
Although yS T cells are present both in the intestinal lamina propria and epithelium, 
special emphasis has been given to the contribution of yô IEL to the resolution of 
inflammation (194). yô IEL produce chemokines (e.g., RANTES or lymphotactin) for the 
recruitment of lymphocytes and macrophages (e.g., MCP-1) (195). Also, neutrophil 
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recruitment into bacterial-induced pulmonary lesions was shown to be dependent on the 
presence ofyô T cells, and correlated with protection from pneumonia (196; 197). 
Additionally, yÔ IEL produce growth factors that promote proliferation and differentiation of 
epithelial cells (198). The possibility of keratinocyte growth factor (KGF) being produced by 
yS T cells was initially investigated in the context of the close interaction between epidermal 
keratinocytes and DETC (198; 199). KGF belongs to the fibroblast growth factor family 
(200). KGF was initially believed to be exclusively produced by stromal cells, mainly 
fibroblasts, and act in a paracrine fashion on epithelial cells (201). Expression of KGF has 
been detected in epithelial cells in vivo, and in DETC stimulated with anti-CD3 in vitro (202-
204). Also, murine DETC isolated from wounded skin expressed KGF mRNA, whereas 
DETC obtained from healthy skin did not. In addition, skin lesions in mice lacking yô T cells 
healed two to three days later than in wild-type mice (205). 
A direct correlation between the production of KGF during intestinal epithelium 
restitution by intraepithelial yô T cells had not been demonstrated until very recently. In a 
murine model of dextran sodium sulfate (DSS) -induced colitis the number of yô IEL were 
increased at the colonic mucosa during the process of tissue repair. These cells were 
associated with damaged areas and were shown to produce KGF by reverse-transcriptase 
polymerase chain reaction. In addition, both KGF- and TCRô-deficient mice had a delay in 
recovery from DSS-induced colitis (206). 
In summary, three basic mechanisms have been reported in regard to the participation 
of yô T cells in mucosal protection. First, by recruiting cells which contribute to control of 
infection. Second, by eliminating activated cells that otherwise would perpetuate 
inflammation, such as activated macrophages or CD4+ T cells; and third, by producing 
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growth factors that contribute to regeneration of the intestinal epithelium and to restoration of 
the epithelial cell barrier (27). 
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CHAPTER 2. DEFERENTIAL REQUIREMENTS FOR THE PROLIFERATION OF 
PORCINE CD4+ AND yS T CELLS TO EXTRACELLULAR BACTERIAL 
ANTIGENS 
A manuscript to be submitted to Immunology 
Raquel Hontecillas, Josep Bassaganya-Riera, and Michael J. Wannemuehler 
Abstract 
dp and yô T cells have different mechanisms of epitope recognition and are 
stimulated by antigens of different chemical nature. Humans and mice have very low 
numbers of circulating yô T cells, whereas in ruminants, chickens, and pigs this T cell subset 
constitutes a significant fraction of the peripheral blood mononuclear cells (PBMC). Both 
peripheral blood CD4+ and yô T cells from pigs immunized with a pepsin-digested bacterin of 
the spirochete Brachyspira hyodysenteriae proliferate in vitro to stimulation with spirochetal 
antigens. This antigenic preparation was used to assess the requirements for the proliferation 
of each of the two subsets in mixed lymphocyte cultures. While CD4+ T cells only responded 
to stimulation with B. hyodysenteriae antigens, but not to exogenous recombinant porcine 
1L-2 whereas yô T cells proliferated when cultures were stimulated with either bacterial 
antigens or exogenous recombinant IL-2. PBMC that had proliferated after 5 days in culture 
expressed high levels of IL-2Ra and neutralization of IL-2 at the beginning of the culture 
period was more efficient in blocking yô T cell than CD4+ T cell proliferation. After 5 days in 
culture, CD4+ cells were the major source of IFN-y, while only a small number of yô T cells 
had the capacity to produce this cytokine. Together, these results indicate that porcine CD4+ 
and yô T cells differ in the mechanisms that drive their proliferation, and in their effector 
functions. 
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Introduction 
Porcine lymphocytes, and more specifically T cells, are characterized by the 
heterogeneous expression of the CD8aa coreceptor and by their diffuse distribution into the 
different compartments of the immune system (I; 2). Although some murine or human T 
cells also express CD8aa, numerically, the CD8aa+ subsets are not as abundant as in pigs. 
In addition, whereas in humans and mice certain cell types are only present at specific 
anatomic locations (e.g., murine yÔ CD8GCGC+ T cells within the intestinal epithelium), this 
clear association between phenotype and tissue distribution has not been demonstrated in the 
pig. Particularly, porcine peripheral blood mononuclear cells (PBMC) are characterized by 
the presence of mature CD41" CD8aa" T cells (3) and by having very high numbers of yÔ T 
cells (2). 
yô T cells differ from afi T cells in several aspects. Through the TCR, a(5 T cells 
recognize peptides presented in association with MHC-class I or II molecules on the surface 
of target cells (i.e., CD8+ cytotoxic T cells) or APC (i.e., CD4+). yô T cells react to antigens 
with chemical composition other than proteins (e.g., phosphoantigens) (4-6) and, although 
costimulation is necessary for cell activation (7), antigen recognition does not require 
processing and presentation by professional APC (8). In addition, the yô TCR is MHC-I and 
II-unrestricted; instead, non-classical MHC molecules, such as T10 and T22 (8), or CD1 (9) 
are ligands for the yô TCR. 
Functional studies of porcine CD4+ CD8acT T cells have indicated that this cell type 
represents memory/effector T helper cells. Moreover, in vitro experiments showed that 
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antigen-experienced CD4+ CD8aa~T cells from peripheral blood upregulate 
CDSaa following a subsequent antigenic exposure (10; 11). Thus, it is currently accepted 
that CD4^ CDSaa-T cells are the precursors of CD4+ CDSaa* T cells. With regard to yô T 
cells, two major subsets have been identified based on the expression of the molecule SWC6 
(12). Porcine SWC6+ cells constitute the majority of the circulating yô T cells and, although 
their function is currently unknown, they are capable of inducing nonspecific cytotoxicity in 
vitro (13; 14). The SWC6' yÔ T cells are phenotypically characterized as CD2+ CD6+ (15), 
and a fraction of this subpopulation additionally expresses CDSaa (16). SWC6" yô T cells 
are found in spleen, secondary lymphoid organs and they are also detectable as circulating 
lymphocytes, although in lower numbers than SWC6+ yô T cells (15) 
Porcine CD4+ and yÔ T cells are thought to contribute to cell-mediated immune 
responses to extracellular bacterial antigens (17). Previous experiments demonstrated that 
immunization with a pepsin-digested bacterin of Brachyspira hyodysenteriae, a gram-
negative spirochete, increases the pool of circulating CD8aa+ PBMC (18), which also 
proliferate to B. hyodysenteriae specific antigen in vitro. Further analysis, indicated that 
CD4+ and yÔ subsets constitute the majority of the T cells proliferating in vitro to antigenic 
stimulation. In addition, CD4+ T cell depletion or blockade of antigen presentation through 
MHC-II greatly diminished proliferative responses of the PBMC (17). Based on these results, 
immunization with this bacterin induces a MHC-II-dependent CD41" T cell response. 
However, because the vaccine affects both CD4 and yô" T cells, additional mechanisms of 
activation might exist besides antigen presentation through MHC-II. We chose this 
immunization regime as a model to investigate differential functional aspects of the two cell 
types in the pig. In the present study, it was determined that the requirements for the 
46 
proliferation of porcine CD4+ and yô T cells are different: while CD4+ T cell responses were 
strictly antigen-dependent, yô T cells proliferated, in addition to specific antigens, to 
stimulation with exogenous IL-2. It is also shown that most of the IFN-y produced in culture 
originates from CD4+ T cells, whereas, in spite of being one of the most numerous cell type 
among PBMC, yô T cells have very reduced capacity of IFN-y production in culture. 
Materials and methods 
Animals and immunization 
Four-week-old cross-bred pigs were immunized with either a squalene-adj uvanted 
protease-digested preparation of Brachyspira hyodysenteriae, or adjuvant alone as previously 
described (18-21). B. hyodysenteriae strain B204 was grown in tripticase soy broth (Becton 
Dickinson; Cockesville, Maryland) supplemented with 5% horse serum (Hyclone, Logan, 
Utah), 0.5% yeast extract (Difco, Detroit, Michigan) and VPI salts under anaerobic 
conditions. Lyophilized bacterial cells were digested by incubation with pepsin (10"3 g, per g 
of lyophilized B. hyodysenteriae) at pH 1.9-2.2 for 25 h at 37° C. The vaccine was prepared 
by mixing at 1:1 (v:v) the pepsin-digested B. hyodysenteriae with the adjuvant (10% of 
squalene/pluronic acid (80:20 v:v) in 2% Tween 80-Saline. Pigs received 3 intramuscular 
doses of either vaccine or adjuvant alone at 15 day intervals. All animal experiments were 
approved by the Iowa State University Committee on Animal Care. 
Isolation of peripheral blood mononuclear cells 
One week after the last immunization PBMC were obtained from whole blood by 
gradient centrifugation. Briefly, a 1:4 dilution of blood in PBS was overlaid onto 4 mL of 
1.077 lymphocyte separation media (Mediate, VA), and centrifuged at 800 x g for 40 
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minutes. PBMC from the plasma/ media interface were aspirated with a pasteur pipete, 
washed 3 times in PBS, and resuspended in complete RPMI 1640 medium (10 % fetal calf 
serum (Hyclone, UT), 25 mM HEPES buffer (Sigma., St. louis, MO), 100 units/ml penicillin 
(Sigma), 0.1 m/ml streptomycin (Sigma), 5 x 10*5 2-mercaptoethanol (Sigma), ImM sodium 
pyruvate (Sigma), 1 mM nonessential aminoacids (Sigma), and 2 mM essential amino acids 
(Mediatech). Cells were enumerated with a Coulter Z1 Single Particle Counter (Beckman 
Coulter, Miami, Florida). 
Proliferation assay 
A total of 20 x 106 PBMC isolated following the procedure described above were 
labeled with the green fluorescent dye PKH67 (Sigma) following manufacturer instructions. 
Briefly, PBMC were aliquoted into 15 mL polystyrene conical tubes and centrifuged at 400 x 
g for 5 min. After eliminating the supernatant, cells were resuspended in 1 mL of Diluent C 
(Sigma). The cell suspension was immediately transferred to a 15 mL polystyrene conical 
tube containing 1 mL of a 2 mM solution of PKH67 dye in Diluent C (Sigma). Cells were 
incubated with the dye for 5 min and the reaction was stopped by the addition of 2 mL of 
Fetal Bovine Serum (Hyclone) and, after 1 min, 4 mL of RPMI 1640. To eliminate excess 
fluorescent dye, cells were washed 3 times in RPMI 1640 and resuspended in complete 
RPMI to a final 2xl06 cells/mL. 
PBMC at 106 cells/ mL were seeded in 96 well flat-bottom microliter plates and 
incubated with complete RPMI only, the pepsin digested preparation of B. hyodysenteriae 
B204 antigen at 5 gg/mL, Concanavalin A at 5 ng/mL (Sigma) or 5 ng/mL of recombinant 
porcine IL-2 (Biosource, MA), in a 200 p.L final volume. After 5 d in culture, PBMC were 
harvested and labeled for the analysis cell surface marker expression by flow cytometry as 
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previously described ( 17). For IL-2 neutralization experiments, polyclonal anti-porcine IL-2 
(R&D Systems, MN) was added at the beginning of the culture period at 3 gg/mL. 
The optimal dose of recombinant IL-2 and the inhibitory concentration of polyclonal 
anti-porcine IL-2 were determined in a titration experiment in which PBMC were incubated 
with increasing amounts of recombinant IL-2, ranging from 0 to 20 ng/mL. Neutralizing IL-
2 antibodies were added at 0, 0.75, 1.5 or 3 mg/mL to triplicate cultures of the various 
amounts of recombinant IL-2. Proliferation was assessed by titriated thymidine 
incorporation. Results showed that addition of more than 5 ng/mL of recombinant IL-2 did 
not result in stronger stimulation and that 3|ig/mL of polyclonal anti-IL-2 completely 
inhibited exogenous IL-2-induced proliferation. 
Antibodies used in flow cytometry 
The following antibodies were used in the proliferation assay for the detection of cell 
surface marker expression: mouse IgG2b anti-porcine CD4 (74-12-1), biotinylated mouse 
IgG2a anti-porcine CD8a (76-2-11), mouse IgGlanti-porcine TCR5 chain (PGBL22A, 
VMRD, Pullman, WA), mouse IgGl anti-porcine CD3 (8E6, VMRD), mouse IgG2a anti-
porcine CD8(3 (PG145A, VMRD), and mouse IgGl anti-porcine CD25 (PGBL25A, VMRD). 
Intracellular IFN-y detection 
PBMC were incubated in 96 well flat-bottom microliter plates at 106 cells/ mL with 
either medium alone, or with the pepsin digested preparation of B. hyodysenteriae B204 
antigen 5 |ig/mL, in a final volume of 200 |AL. On d 5, cultures were stimulated with 50 
ng/mL of phorbol myristate acetate (PMA) (Sigma) and 100 ng/mL ionomycin (Sigma). 
Golgi transport was blocked by the addition of 4 |xL of Golgi Stop (Pharmingen, San Diego, 
CA) for every 6 mL of cell culture. After CD4/CD8a and TCRyô/CDSa cell surface staining, 
49 
cells were fixed and permeablized with the Cytofix-cytoperm kit (Pharmingen) following 
manufacturer's instructions. PE-labeled mouse IgGl anti-porcine IFN-y (P2G10, 
Pharmingen) was used for intracellular cytokine detection. Equally stained non-PMA and 
ionomycin-stimulated cultures were used as negative controls, and mouse IgGl-PE (Sigma) 
was used as isotype control. 
Statistical analysis 
Data were analyzed as a randomized complete block design. Analysis of variance (ANOVA) 
was used to investigate the main effects of vaccination. ANOVA was performed using the 
general linear model procedure (GLM) of SAS. Differences with P < 0.05 were considered 
significant. 
Results 
Lymphocyte activation and proliferation in vitro 
Previous studies demonstrated that immunization with a B. hyodysenteriae bacterin 
induced antigen-specific T cell proliferation (21). In order to further investigate these 
responses, PBMC from control and immunized animals were cultured with medium alone, or 
with pepsin-digested whole cell B. hyodysenteriae antigens. As it had been reported before, T 
cells from immunized animals proliferated in vitro in the presence of the pepsin digested B. 
hyodysenteriae antigens as determined by the decrease in PKH67 mean fluorescence 
intensity of CD3+ PBMC (figure 1 A). The same results were obtained by 3H-thymidine 
incorporation (data not shown). In addition, a fraction of CD3" cells from immunized pigs 
(5.6 ± 0.04 vs. 1.3 ± 0.34 % in non-immunized) also proliferated to antigenic stimulation, 
although we did not phenotypically characterize the responding CD3~ lymphocytes. 
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Anti-CD25 staining of PBMC from immunized pigs cultured with B. hyodysenteriae 
antigens (figure IB) indicates that antigenic stimulation upregulated cell-surface IL-2Ra . 
Based on the expression of CD25 on cells from immunized pigs that had proliferated, IL-
2Ra upregulation correlated with cell division. However, by d 5, a small proportion of non-
stimulated PBMC from immunized pigs (6.09 ± 0.9), or PBMC from control pigs cultured 
with either medium (7.5 ± 2.7) or B. hyodysenteriae antigens (8.9 ± 0.02) stained positive for 
IL-2Ra, although these cells failed to proliferate. 
Subset analysis of T cells responding to B. hyodysenteriae 
In order to dissect the pool of T cells that had proliferated, CD4T(i.e., helper a(3 T 
cells), CD8afT (i.e., cytotoxic a(3 T cells), and yô T cells were individually analyzed. An 
additional T cell subset (i.e., TCR CD4~ CD8aaT) has been identified in porcine PBMC; 
however, due to the lack of monoclonal antibodies specific for either the porcine TCRa or (3 
chains, it was not possible to analyze this subset individually. Proliferation results show that 
6.4 ± 2.3 % of CD4+ and 8.3 ± 3.97 % ofy5 T cells isolated from immunized pigs 
proliferated in vitro to B. hyodysenteriae antigens. Thus, these two subsets account for the 
vast majority of the T cells responding to antigenic stimulation (figure 2). No proliferative 
responses were detected in CD8a|3+ T cells. Additionally, when non-specific T cell responses 
were detected (i.e., PBMC from immunized pigs cultured with medium or PBMC from 
controls cultured with B. hyodysenteriae antigens), it was due to proliferation of yô T cells. 
Both CD4+ and yô T cells can be further subdivided based on the expression of 
CD8a. In order to determine differential responses within CD4+ or y8 T cell subsets, cells 
were stained with both anti-CD4 and anti-CD8a, or anti-TCRS chain and anti- CD8a for the 
phenotypic analysis of cells that had proliferated after 5 d in culture. Results show that when 
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PBMC from immunized pigs were stimulated with B. hyodysenteriae antigens, 9.9 ± 3.9 % of 
CD4* cells were CD4+ CDSaa" PKH67 10 and 12.4 ±6 % were CD4+ CDSaa* 
PKH67 lo. With regard to the yô T cell subset, 17.13 ± 8.0 of the cells that proliferated were 
yÔ CDSaa", wheras only a small fraction of TCRyS CDSaa* (1.4 ± 0.5 %) proliferated in the 
presence of B. hyodysenteriae antigens (Table I). Also, non-specific background 
proliferation (7.4 ± 2.4) was observed for TCRyô CDSaa" T cells isolated from non-
immunized animals in cultures where bacterial antigens were added. 
Differential requirements for proliferation of CD4* and y& T cells 
Lymphocytes that had proliferated during the 5 d in culture upregulated and 
maintained cell surface CD25 expression (figure I). In order to determine the IL-2 
requirements for activation and proliferation of the different cell types responding to 
antigenic stimulation, PBMC were cultured with either B. hyodysenteriae pepsin-digested 
antigen or medium supplemented with recombinant porcine IL-2. This cytokine alone was an 
insufficient stimulus for a(3 T cells (i.e., CD4+ and CD8a0*) to proliferate (figure 3A). 
However, in some instances, CD4+ T cells weakly responded (data not shown). Cell 
phenotype based on CDSaa expression indicated that only CD4*CD8aa~, but not 
CD4*CD8aa* T cells could undergo cell division following stimulation with exogenous IL-
2. In contrast to a(3 T cells, a significant proportion of yô T cells (13.21 ±5.7) responded to 
the addition of this cytokine (figure 3 A). The majority of the yô T cells that proliferated were 
CDSaa" as well. No significant differences were found between PBMC isolated from control 
or B. hyodysenteriae-immunized pigs in their proliferation to the addition of exogenous IL-2. 
Treatment of cultures with neutralizing anti-IL-2 antibodies at the beginning of the 
culture period, blocked proliferation of yô CDSaa" T cells to exogenous IL-2, and resulted in 
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50 % reduction of the proliferative response of this cell type when PBMC from immunized 
pigs where stimulated with antigen (figure 3 B). With regards to the CD4+ pool, proliferation 
of CD4+CD8aa+ T cells to B. hyodysenteriae diminished from 21.01 ± 4.58 to 11.9 ± 3.6 % 
by the addition of lL-2-neutralizing antibodies (figure 3B). 
CD4* T cells are the major source of IFN-y 
Previously, we reported the presence of IFN-y-producing cells in B. hyodysenteriae-
stimulated PBMC from vaccinated pigs. Additionally, we showed that the IFN-y response 
was CD4+T cell-dependent because in vitro CD4T cell depletion decreased the numbers of 
IFN-y-producing cells (18). In the present study, intracellular cytokine staining results 
indicate that CD4+T cells are the major source of IFN-y in PBMC (figure 4). In addition, 
when CD4* T cells were stimulated with B. hyodsyenteriae, the percent IFN-y+-producing 
cells decreased (2.53±1.09 to l.07±0.1) along with the mean fluorescence intensity of the 
cytokine staining (1758.7±114 to 436±18.). This effect was observed in all pigs, irrespective 
of the in vivo treatment, although it was more marked in CD4+ cells from immunized pigs. 
On the other hand, very few yô T were able to produce IFN-y in vitro. However, the percent 
of cytokine-positive yÔ T cells increased in both vaccinated (from 0.687± 0.158 to l.52±0.82) 
and controls (from 0.69±0.19 to 1.157 ±0.827) after stimulation with B. hyodysenteriae 
antigens. 
Discussion 
Our results show that both a(3 and yô T cells respond in vitro following antigenic 
stimulation, however, the requirements for activation are different for the two T cell subsets. 
The fact that cells that had divided after 5 d in culture (i.e., lower intensity of PKH67 
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staining) expressed high levels of CD25, and that IL-2 neutralization blocked proliferation, 
suggest that IL-2 is necessary for porcine T cell proliferation. However, based on the 
responses to exogenous IL-2, the addition of this cytokine alone is insufficient to induce 
CD4+ and CD8aP T cell division. The antigen used in vitro in these experiments was the 
pepsin-digested preparation of B. hyodysenteriae. As it would be expected for an 
extracellular antigen. CD4+ (i.e, T helper) but not CD8aP T cells (i.e., cytotoxic T cells) 
responded to antigenic stimulation. Thus, both IL-2Ra and TCR-derived signals were 
necessary for «P T cell activation as measured by proliferation assays. 
In contrast to aP T cells, yô T cells proliferated in response to specific antigen as well 
as to addition of exogenous IL-2. Earlier studies have shown that blockade of antigen 
presentation through MHC-II. or culture of PBMC depleted from CD4+ T cells diminished 
yô T cell proliferation to B. hyodysentariae antigens (17). It could be interpreted that yô T 
cell proliferation is secondary to CD41"T cell activation. In this regard, it could be proposed 
that B. hyodysenteriae-antig&n specific cells are within the CD4™ pool, and yô T cell 
proliferation is bystander to the activation of antigen-specific CD4+ T cells. A similar 
interaction between CD4+and yô T cells was described for in vitro pseudorabies virus-
stimulated PBMC from immunized pigs (22). It remains unknown whether, in addition to IL-
2, TCR signals are needed for proliferation of porcine yô T cells. 
Yang et al. reported that, in contrast to (%P T cells, porcine yô T cells failed to 
proliferate in vitro following stimulation with a panel of anti-CD3 monoclonal antibodies. 
These results suggest that signal transduction events that lead to TCR activation are distinct 
for porcine aP and yô T cells (23). Comparative studies of the structure of the human aP and 
yô TCR have shown differences that constitute the basis for some of the biological properties 
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of each the two cell populations. Among these, the fact that the hinge region of the yô TCR 
has additional amino-acid residues, and that the domain that has been proposed to interact 
with CD3E is shorter in the <*P TCR, suggest that aP and yô TCR form different signaling 
complexes (24). In fact, the molecular composition of the TCR-CD3 complex in human and 
murine yô T cells differs from aP T cells in that the first lacks CD3S subunits. However, at 
the functional level, the threshold for TCR activation appears to be lower in yS than in (%P T 
cells based on calcium mobilization, extracellular signal-regulated kinase (ERK.) activation, 
and proliferation following stimulation with anti-CD3 (25). 
Our results do not provide sufficient evidence to support the concept that all yô T 
cells that proliferated in B. hyodysenteriae-stimulated cultures responded solely to IL-2-
induced stimulation. A portion of yô T cells could have responded independently from CD4T 
T cells and, equally to ctp T cells, also require TCR activation for proliferation. This could be 
explained by non-MHC-II-restricted specific recognition of B. hyodysenteriae epitopes by yô 
T cells. This hypothesis is supported by the fact that yô T cell proliferation at background 
levels was observed when PBMC from non-immunized pigs were cultured with bacterial 
antigens. Also, because yô T cells proliferated in the absence of B. hyodysenteriae antigens 
but in the presence of exogenous IL-2, an additional CD4* and B. hyodysenteriae antigen-
independent mechanism must exist for the activation of yô T cells. A CD41"-independent 
pathway of yô T cell activation in vitro by an unknown ligand present on monocytes and 
granulocytes has been described in cattle (26). Porcine and bovine yô T cells have similar 
phenotypic characteristics. It is also probable that they also have functional aspects in 
common. A similar ligand might also exist in porcine cells, however, while stimulation with 
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this ligand induced IFN-y production by bovine cells, in our experiments yô T cells failed to 
produce this cytokine. 
Several in vivo models have shown an increase in yô T cells following activation of 
a(3 T cells (27-29). Such changes in the yô T cell population initially depend on the 
production of IL-2 (30; 31). It has been suggested that a negative feed back loop is 
established between yô and a(3 T cells by which, antigen-specific a(3 T cell responses are 
inhibited by the expanded yô T cells (28). Activated yô T cells express high levels of Fas 
ligand and can induce apoptosis of Fas* CD4+ T cells (32). Porcine yô T cells have non­
specific cytotoxic activity in vitro, although the molecular basis has not been investigated. 
Our results show that B. hyodysenteriae antigen stimulates CD4* CDSaa™ and CD4* 
CDSaa* from immunized pigs to proliferate. In addition, antigenic stimulation decreased the 
number of CD4+ cells producing IFN-y. It is possible that the activated yô T cells 
proliferating in B. hyodysenteriae-stimulated cultures downregulated CD4+ 
CDSaa" and CD4+ CDSaa* responses (i.e., less IFN-y production). 
The magnitude of in vitro T cell proliferation in antigen recall responses is a 
functional parameter frequently used to evaluate the efficacy of a cellular immune response. 
T cell proliferative responses to an antigen indicate the presence of antigen-specific cells, and 
therefore the generation of immunological memory. We have shown in a mixed lymphocyte 
culture of porcine PBMC that vaccination with a gram-negative spirochete bacterin generated 
antigen-dependent CD4 T cell responses. Additionally, yô CDSaa" T cells proliferated in 
vitro. We analyzed yô CDSaa* T cells separately because we had reported that CDSaa* 
PBMC from B. hyodysenteriae-immunized pigs were increased in vivo, and proliferated in 
antigen recall responses. In these experiments, yô CDSaa* T cells failed to respond to either 
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antigen or IL-2 stimulation. Future studies should address the subset composition (i.e., 
SWC6+ or SWC6") of the responding yô T cells. 
Immunization with this bacterin protects pigs against B. hyodysenteriae-indxiced 
colitis. We are currently investigating the function of CD4T and yô T cells at the colonic 
mucosa during infection. Very few studies have addressed the role of porcine yÔ T cells in 
vivo. SWC6+ yS T cells (i.e., CD2" CDSaa") were recruited to skin inflammatory lesions 
induced phytohemagglutining injection (33; 34). In several murine models, yô T cells have 
been reported to downregulate inflammation (28). If these responses were beneficial, it 
would be of interest to elucidate the basis of the CD4T-yô T cell interactions and whether this 
mechanism should be exploited for the treatment or prevention of inflammatory diseases. 
Table 1. Cell surface phenotype of proliferating peripheral blood T cell subsets from 
control or immunized pigs ' 
Medium2 B. hyodysenteriae antigen 
Phenotype3 Control Immunized Control Immunized 
CD4* CDSaa" PKH671"4 
CD4* CDSaa1- PKH67'0 
yô CDSaa" PKH67loS 
yô CDSaa' PKH6710 
2.228 ± 0.998 
1.263 ±0.709 
3.804 ±2.061 
0.438 ±0.279 
2.244 ±0.826 
0.961 ±0.261 
7.226 ± 4.226 
0.326 ±0.161 
3.345 ± 1.422 
1.831 ±0.891 
7.366 ±2.414 
0.689 ±0.401 
9.894 ±3.971*6 
12.394 ±6* 
17.131 ±8.063* 
1.383 ±0.487 
1 Results are expressed as mean (n=5) percentage of CD4*or TCR5* cells that had proliferated (i.e., PKH6710) 
after 5 d in culture. 
" Peripheral blood mononuclear cells isolated from control and B. hyodysenteriae-immumzsd pigs were labeled with 
PK.H67 and cultured with either complete RPMI medium or 5 gg/mL of B. hyodysenteriae pepsin-digested antigenic 
preparation. 
3 Cells were harvested on day 5 and double stained with monoclonal antibodies specific for CD4 and CD8a or 
TCRS and CD8a, and analyzed by 3 color flow cytometry. 10,000 events within the viable cell gate were 
acquired. 
4 CD4* cells within the mononuclear viable gate were analyzed by plotting CD8a versus RK.H67. 
5 TCR5* cells within the monocyte viable gate were analyzed by plotting CD8a versus PK.H67. 
6 *, f-value < 0.05 when compared to the non-immunized control group. 
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Figure 1. Proliferation (A) and CD25 expression (B) of PBMC from an immunized 
(left panel) and a non-immunized control pig (right panel) after 5 d in culture with 
either RPMI medium or B. hyodysenteriae antigens. PBMC were isolated one week 
after three intramuscular immunizations with a pepsin-inactivated B. hyodysenteriae 
bacterin. CD3 staining (top row) indicates that T cells from immunized pigs 
specifically responded to stimulation with spirochetal antigens. The forward versus side 
scatter plot shows the cells included in the analysis (i.e., live mononuclear cells). Plots 
are representative from 2 experiments with a total of 5 pigs per group. 
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Figure 2. Proliferation of CD41", CD8afT and yô T cells from an immunized (left panel) and 
a non-immunizad control pig (right panel) after 5d in culture with either RPMI medium or B. 
hyodysenteriae antigens. PBMC were isolated one week after three immunizations with a 
pepsin-inactivated B. hyodysenteriae bacterin. CD4+ and y5 T cells from vaccinated pigs 
account for the majority of the CD3+ proliferating cells. The forward versus side scatter plot 
shows the cells included in the analysis (i.e., live mononuclear cells). Plots are representative 
from 2 experiments with a total of 5 pigs per group. 
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Figure 3. IL-2 requirement for the proliferation of porcine T cells. 
A) y§ T cells proliferated to the addition of 5 ng/mL of exogenous porcine recombinant IL-2 
while neither CD4 nor CD8«P+ T cells responded to stimulation with this cytokine 
alone. Plots correspond to 5 d cultured PBMC from a representative non-immunized 
control pig. Two experiments were conducted with a total of 4 pigs per group. Cells 
included in the analysis correspond to live mononuclear cells gated as indicated in the 
forward versus side scatter plot. 
B) IL-2 neutralization blocked proliferation of y8 CD8~ T cells stimulated with exogenous 
porcine IL-2 (lower row in right panel). In PBMC cultures from immunized pigs 
stimulated with B. hyodysenteriae antigen, the addition of anti-porcine IL-2 antibodies at 
the beginning of the culture period diminished proliferation of both CD4+CD8aot+ (top 
row in left panel) and yô CDS" T cells (bottom row in left panel), although proliferative 
responses of the latter were more affected by IL-2 neutralization. CD4+ or TCR§+ T cells 
within the viable gate were analyzed by plotting CD8a versus PKH67 as indicated in the 
CD4 versus CDSa or TCR5 versus CDSa plots, respectively. Plots are representative of 
one experiment with 3 pigs per group. 
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Figure 4. IFN-y production by CD4+ and yS T cells from an immunized (top row) 
and a non-immunized control pig (bottom row). PBMC were isolated from 
controls and B. hyodysenteriae pepsin-digested-immunized pigs one week after the 
third immunization. After 5d in culture with either medium alone or B. 
hyodysenteriae antigens, cells were stimulated with PMA and ionomycin for 4 
hours for the detection of intracellular IFN-y by flow cytometry. CD41" T cells are 
the major source of IFN-y, and stimulation with B. hyodysenteriae antigens 
modulates IFN-y production by CD41" and yô T cells. Initial gate was set on the 
mononuclear cell population as indicated in the forward versus side scatter plot. 
Plots are representative from one experiment of 3 pigs per treatment. 
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CHAPTER 3. MODIFICATION OF THE LYMPHOCYTE COMPOSITION AND 
CYTOKINE ENVIRONMENT DURING Brachyspira hyodysenteriae-INDUCED 
COLITIS BY SYSTEMIC IMMUNIZATION WITH A PROTEINASE DIGESTED 
BACTERIN 
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J. Wannemuehler. 
Abstract 
Systemic immunization has proven to be of limited efficacy in preventing bacterial 
mucosal infections. Here, we have examined the mechanism by which an enteric disease can 
be ameliorated by parenteral immunization with a protease-digested bacterin of the 
spirochete Brachyspira hyodysenteriae. We have previously shown that systemic 
immunization with B. hyodysenteriae induced proliferation of CDSaa*, CD4* and yÔ* T cells 
to specific B. hyodysenteriae antigens. Here, we have examined how the colonic profiles of 
immunoregulatory and pro-inflammatory cytokines as well as the lymphocyte subset 
distribution were influenced by immunization and/or challenge with B. hyodysenteriae. 
Following immunization with the protease-digested B. hyodysenteriae bacterin, colonic 
inflammation was triggered by challenging the pigs with B. hyodysentariae. Colonic mucosal 
lesions and lymphocyte subset distribution were evaluated by histology and 
immunohistochemistry. Immunoregulatory and pro-inflammatory cytokines were assayed in 
colonic tissue. Immunization up-regulated TNF-a and IL-1 (5 mRNA expression. In addition, 
TGF-(3l mRNA was increased in infected pigs previously immunized. Finally, vaccination 
diminished the loss of yô T cells observed following the bacterial challenge and favored a 
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decrease in numbers of lamina proprial CD4+ cells. Therefore, we report a unique case of 
parenteral immunization that regulates colonic lymphocyte subset distribution and cytokine 
expression. This model of immunoregulation of colitis may have important applications in 
the treatment of inflammatory bowel disease in humans. 
Introduction 
Enteric inflammatory processes associated with inflammatory bowel disease (IBD) 
have been studied using a number of murine models of coltis (IBD) (I). Antigens expressed 
by the intestinal normal flora contribute to the pathogenesis of IBD by triggering abnormal 
immune and/or inflammatory responses (1; 2). Excessive activity of T helper (Th) cells (i.e., 
CD4*), especially polarized Thl, induces a cytokine imbalance often observed in Crohn's 
disease patients (3-6). On the other hand, Th cells are controlled by regulatory T cells (i.e., 
Th3. Trl or CD4+ CD25+), mainly through the production of suppressor cytokines such as 
transforming growth factor-^ (TGF-P) or IL-10 (7-10). Thus, defects in the regulation of T 
cell responses contribute to the pathogenesis of inflammation by negatively affecting 
mucosal homeostasis (1). 
Brachyspira hyodysenteriae is a bacterial enteric pathogen that causes swine 
dysentery, a severe hemorrhagic colitis (11). The bacteria invade the colonic mucosa without 
spreading systemically (12). Similarly to IBD, the normal intestinal flora is involved in the 
disease pathogenesis (13). One of the virulence factors of B. hyodysenteriae is a low 
molecular mass P-hemolysin that was shown to induce apoptosis of intestinal epithelial cells 
(14). Following loss of the epithelial cell barrier, excessive exposure of the underlying 
mucosa to luminal antigens triggers a severe inflammatory response. 
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Parenetral immunization of pigs with a pepsin-inactivated bacterin of B. 
hyodysenteriae ameliorates clinical and histopathological signs associated with swine 
dysentery (15). CD8act\ CD4+ and yô T cells isolated from peripheral blood of immunized 
pigs respond in vitro to stimulation with B. hyodysenteriae antigens (16-19); however, the 
effect that vaccination has on these cell subsets in the colonic mucosa during infection has 
not been investigated. In the present study it was shown that both vaccination and infection 
modulated lymphocyte composition of the colonic mucosa. Particularly, it is shown that the 
protection against disease induced by immunization correlated with a decrease in lamina 
proprial CD4+ cells. Furthermore, although infected pigs had lower yÔ intraepithelial 
lymphocytes (IEL), those that were previously immunized maintained higher numbers of this 
lymphocyte subset. These phenotypic changes were accompanied by an increase in TGF-
P mRNA in colonic tissue recovered from immunized pigs. Immunization also increased the 
expression of IL-1(3 and TNF-a. Thus, on the basis of these results, systemic immunization 
modified the outcome of colonic inflammatory and immune responses. 
Materials and methods 
Experimental design 
Immunization: a total of 12 four-week old pigs were immunized with either a squalene-
adjuvanted, pepsin-digested preparation of Brachyspira hyodysenteriae (n=6) or adjuvant 
alone (n=6). The vaccine was prepared as previously described (20). Pigs received 3 
intramuscular doses at 15 days intervals. 
Challenge: two weeks after the third immunization, half of the control or immunized pigs 
were orally challenged with two doses of 1010 CFU of B. hyodysenteriae strain B204 
given on consecutive days. All cultures used for infection studies were >90% motile and 
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had been passed in vitro 23 to 25 times. After challenge, pigs were monitored daily for 
clinical signs of disease (e.g., diarrhea, depression, anorexia, abdominal pain, and 
dehydration). Stools were observed and scores were based on consistency: (0), no diarrhea, 
stools formed: (1) mild, (2) moderate, and (3) severe diarrhea. Stools were also observed for 
the presence of blood and/or mucus. Clinical response scores were calculated daily following 
challenge by adding the diarrhea score (i.e., 0 to 3) plus a 1 for the presence of blood and/or a 
1 for the presence of mucus. All animal related procedures were approved by the Iowa State 
University Animal Care and Use Committee. 
Necropsy: 15 days post-challenge pigs were anesthetized by administration of Rompun 
(Bayer; Shawnee, KS)/Telazol (Fort Dodge Laboratories; Fort Dodge, IA) intramuscularly 
and euthanized via electrocution. At necropsy, swabs of cecal and spiral colon contents were 
streaked onto modified BJ blood agar plates containing antibiotics for isolation of B. 
hyodysenteriae (21). Sections of spiral colon and cecum were obtained, fixed in 10% 
buffered formalin, later embedded in paraffin, and then sectioned for histological 
examination. Samples of colon and mesenteric lymph nodes were embedded in RNA Later 
(Ambion Inc., Austin, TX) for isolation of total RNA and analysis of cytokine m RNA 
expression. For immunohistochemistry, samples of colonic tissue were placed in tissue 
freezing medium (Triangle Biomedical Sciences, Durham, NC) and snap frozen in 
ethanol/dry ice bath. 
Histopathological evaluation of colonic samples. 
Hematoxilin-eosin (H & E)-stained sections from colon and cecum were labeled with 
accession numbers lacking any reference to immunization or infection status (i.e., blinded to 
evaluator). Histological evaluation was conducted on the basis of gland depth (i.e., expressed 
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as crypt depth as a function of crypt width), metaplasia/hyperplasia (i.e., increased cell 
turnover and basal cell basofilia, or goblet cell metaplasia), lamina propria vascular change 
(i.e., capillary dilation and lamina propria hemorrhage), inflammation and submucosal 
change (i.e.. inflammatory cells infiltrates at the lamina propria or submucosa), and epithelial 
erosions (i.e., 1 ) no erosion, 2) mild erosion and 3) severe erosion). 
Determination of the lymphocyte subset composition of the mucosa by 
immunohistology. 
Frozen colonic tissue embeded in OCT tissue freezing medium were cut at 5 to 7 |im-
thick sections on a cryostat at - 18 °C. Sections were placed on poly-L-lysine coated slides, 
fixed in 95% methanol for 2 minutes and soaked in cryopreservative solution (0.5 M sucrose, 
0.006 M MgCh, 50 % glycerol) for 10 minutes. Slides were stored at - 20 °C until processed 
for immunohistchemistry. Prior to staining tissues with monoclonal antibodies, slides were 
warmed to room temperature and rehydrated in 0.5 M Tris solution. Endogenous peroxidase 
activity was blocked by adding 0.3 % hydrogen peroxide for 10 minutes. Non-specific 
binding was blocked by adding immunohistochemistry buffer containing 5 % normal goat 
Serum/ 3 % bovine serum albumin/tris buffer (NGS/BSA/Tris) solution at room temperature 
for 2 hours. Slides were incubated with the primary antibody solution overnight at 4 °C. 
Primary antibodies were diluted in NGS/BSA/Tris. Sections were stained with anti-porcine 
CD4 (74-12-1 hybridoma supernatant), anti-porcine-CD8a (76-2-11 hybridoma supernatant), 
anti- porcine TCRÔ (PGBL22A, VMRD, Pullman, WA), or anti-porcine CD3 (8E6, VMRD). 
Prior to the incubation with the secondary antibodies, slides were rinsed with Tris solution. 
Peroxidase-conjugated goat anti-mouse IgG (H+L) (Jackson ImmunoResearch, West Grove, 
PA) diluted at 1:300 in NGS/BSA/Tris was used for the detection of anti-porcine CD4, anti-
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porcine CD3, and anti-porcine TCR8. Biotinylated goat anti-mouse IgG2a F(ab')i fragments 
(Southern Biotechnologies Associates Inc. Birmingham, AL) were used for the detection of 
anti-porcine CD8a primary antibody diluted in NGS/BSA/Tris at 1:250. All secondary 
antibodies were incubated for 2 hours at RT. Slides were then treated with peroxidase-
conjugated streptavidin, diluted in Tris solution (1:500) and incubated for 1 hour (RT). 
Positive antibody binding was visualized with diaminobenzediene (Biomedia Corporation, 
Foster City. CA). Tissue sections were counterstained with Instant Hematoxylin (Shandon, 
Pittsburg, PA) and coversliped with Immu-mount (Shandon). The numbers of CD4+, CD8a+, 
CD3T, and TCRyfT cells in either epithelium or lamina propria were enumerated for each pig 
and antibody staining. Data are presented as the sum of positive-staining cells in 5 randomly 
chosen fields of 0.375 mm2 area, observed at 400 x magnification. 
Isolation of total RNA. 
Total RNA from full-thickness colonic tissue recovered with a 3 mm diameter punch 
biopsy 15 days after challenge was isolated using the total RNA isolation MiniKit (Qiagen, 
Valencia. CA) following manufacturer's instructions. RNA was diluted in 0.02% diethyl 
pyrocarbonate (DEPC)-treated water (Qiagen). RNA concentration and purity were 
determined using a spectrophotometer at an optical density (OD)2eo and OD26o/OD2so ratios, 
respectively. All samples had OD260/OD280 ratios above 1.80 corresponding to 90-100% pure 
nucleic acid. Samples were stored at —70°C until processed. 
Ribonuclease protection assay 
A custom template set (Pharmingen, San Diego, CA) was used for the synthesis of 
antisense-RNA probes for the detection of porcine IL-4, IL-12p40, TNFa, IL-lfî, TGF-
Pt, IL-6, IFN-y, L32 and GAPDH mRNAs. [32P]UTP (Amersham Pharmacia)-labeled probes 
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were synthesized with an in vitro transcription kit (Pharmingen) following manufacturer's 
instructions. Target RNA was hybridized overnight to the antisense RNA probes. Single-
stranded unbound RNA and free probe were subjected to RNases A and Tl digestion. 
Protected double-stranded RNA duplexes were purified and resolved on a urea-
polyacrylamide denaturing gel. The gel was dried for I h at 80 C and bands were visualized 
and quantified by phosphorimaging. 
Statistical analysis 
Post-challenge, data were analyzed as a 2 X2 factorial arrangement of treatments 
within a split-plot design. Analysis of variance (ANOVA) was used to investigate the main 
effects of vaccination and infection as well as the interaction between infective status and 
vaccination. ANOVA was performed using the general linear model procedure (GLM) of 
SAS. Differences with P < 0.05 were considered significant. 
Results 
Vaccination ameliorates the severity of B. hyodysenteriae-induced colitis 
Following challenge, pigs were monitored daily for the development of clinical signs 
associated with B. hyodysenteriae-induced colitis. No signs were observed until 4 days post­
infection (figure 1). Disease progression from this point was similar for both of the groups 
that were challenged although severity was milder in the group previously immunized with 
the B. hyodysenteriae bacterin, as shown by the lower daily average score. Examination of 
colonic sections recovered on day 15 post-infection revealed the typical microscopic lesions 
associated with B. hyodysenteriae;-induced colitis. A total lesion score was generated based 
on grading changes in gland depth, hyperplasia/metaplasia, lamina proprial vascular change, 
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submucosal change, inflammation, and superficial epithelial erosions (Table 1), as described 
in the materials and methods section. No differences in total average cecal scores were found 
between the different treatment groups (data not shown). In the colon, the average total score 
of immunized and infected pigs was lower (15.6± 5.7) than that of the corresponding 
challenged pigs not receiving immunization (19.6± 4.8). All infected pigs were culture 
positive for B. hyodysenteriae the day they were necropsied. The histopathological score in 
the non-infected groups was equal (11.3± 2.4and 11.33± 1.8) for the non-vaccinated and non-
infected and vaccinated and non-infected pigs. 
Severe inflammation was manifested by increased mucosal thickness due to a 
pronounced hyperplasia of crypt epithelial cells, which was accompanied by increased 
cellular basophilia, and increased mitotic figures. This lesion was associated with multifocal 
inflammatory cell infiltrates across the lamina propria muscularis (figure 2H). On the other 
hand, pigs recovering from disease (as determined by clinical evaluation) showed goblet cell 
metaplasia with excess mucus production (figure 2G). Non-vaccinated and infected pigs had 
a 2.33 ± 0.44 hyperplasia/metaplasia average score, with 13 ± 2.67 gland depth whereas the 
score for infected and vaccinated pigs were 1.66 ± 1.11 for hyperplasia/metaplasia, and 
10.31 ±3.1 for gland depth. Thus, vaccinated and non-vaccinated groups differed in the 
intensity rather than in the type of lesions developed following challenge. 
Lymphocyte distribution in the colonic mucosa 
Studies of the lymphocyte composition of the intestinal mucosa have revealed 
regional specialization between the small and large intestine, and between lamina propria and 
epithelium. Also, species-specific differences have been reported. Phenotypic 
characterization of the small intestine of pigs revealed the absence of CD4+ cells within the 
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epithelium. Immunohistochemical analysis of colonic sections showed the same distribution 
of CD4+ cells (figure 3B). yô T cells are present in both compartments of the colonic mucosa, 
as lamina propria lymphocytes (LPL) and as intraepithelial lymphocytes (IEL) (figure 3C). 
CDScT cells follow the same distribution as y8 T cells (not shown). 
While yô LPL were dispersed in the tissue, clusters of CD4+ cells were present across 
the lamina propria. These aggregates were more abundant in tissues recovered from B. 
hyodysenteriae infected pigs (figure 4A-4C). In addition, immunohistological analysis of 
longitudinal sections revealed that the multifocal cellular infiltrates found in the lamina 
propria muscularis (figure 2H) were mainly composed of CD4+ T cells. yÔ T cells were also 
detected in these lesions although in much smaller numbers (figures 4D-4F). 
Changes in the lymphocyte subset composition of the colonic mucosa induced by 
immunization and/or challenge. 
Peripheral blood CD4^and yô T cells from immunized pigs respond in vitro to B. 
hyodysenteriae antigens. In order to investigate whether immunization affects the 
lymphocyte composition of the mucosa, CD3+, CD4+, yÔ T cells and CD8a* from the colonic 
epithelium or lamina propria were enumerated. Immunization decreased the numbers of 
CD4+ cells in the lamina propria (figure 5A). This effect was found irrespective of challenge 
status. Changes were also detected at the epithelium, with lower numbers of epithelial T cells 
(i.e., CD3+), consistent with a decrease in yô IEL. Vaccination, however, attenuated the loss 
of this T cell subset (figure 5B). 
Proinflammatory cytokine expression 
A ribonuclease protection assay was utilized to investigate how infection and/or 
immunization modulated the expression of cytokines in vivo (Figure 6). Transcriptional 
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activity of TNF-a and IL-1(3 was increased in the group of vaccinated and infected pigs when 
compared to those pigs infected only and non-infected pigs. Immunization also upregulated 
the expression of IL-1(3. In addition, vaccinated and infected pigs had higher expression of 
TGF-(3, mRNA. Infection also stimulated the expression of IFN-y and IL-6 without any 
significant differences between immunized and non-immunized pigs (data not shown). 
Finally, transcriptional activity of IL-4 or IL-12p40 was undetectable (not shown). 
Discussion 
Protection induced by systemic immunization with a proteinase-digested bacterin of 
B. hyodysenteriae correlates with changes in the lymphocytic composition of the colonic 
mucosa and in the proinflammatory cytokine expression. B. hyodysenteriae is a non-invasive 
bacterium which disrupts the colonic epithelium (14). Lymphocytes are part of the 
population of leukocytes infiltrating the lamina propria of inflammatory lesions induced by 
B. hyodysenteriae. Our results show that immunization decreased the numbers of CD4+ cells 
in both infected and non-infected pigs. In the former group, these changes were accompanied 
with a milder disease manifestation and less severe microscopic lesions. Interestingly, the 
expression of the proinflammatory cytokines TNF-a and IL-1(3 m RNA was higher in 
vaccinated pigs. 
The cytokine profile of colonic tissue recovered from infected pigs is suggestive of a 
predominant Thl response. In the majority of murine models of colitis, lesions result from 
aberrant Thl responses, irrespective of the factor triggering the process (1). These pathogenic 
CD4+ T cells are specific for antigens expressed by members of the normal flora (2; 4). The 
presence of members of the normal colonic flora is also necessary for the development of B. 
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hyodysenteriae-induced colitis because disease was not detected in germ-free/gnotobiotic 
pigs or when mice were selectively depleted of gram negative bacteria via antibiotics prior to 
challenge (22-25). Antibiotic treatment has also proven to be effective in decreasing 
intestinal inflammation in murine models of IBD (26; 27). Thus, part of the LP CD4^ cells 
might be responding to antigens from the colonic flora. 
An interesting finding is that vaccination alone modified the expression of 
proinflammatory cytokines at the colonic mucosa. B. hyodysenteriae produces a 
lipopolysaccharide (LPS) that stimulates the production of IL-1(3 and TNF-a by 
macrophages (28; 29). However, because the vaccine was administered parenterally (i.e., 
intramuscular), the increase in proinflammatory cytokine expression is secondary to the 
cellular immune response induced by vaccination. Peripheral blood CD8aar, CD4+, and yôT 
cells from immunized pigs respond in vitro to B. hyodysenteriae antigens (17-19; 30). Also, 
the production of IFN-y in antigen-recall responses to B. hyodysenteriae was shown to be 
CD4-dependent (20). Thus, it is possible that immunization favors differentiation of naïve 
cells into Thl cells that home to the colonic mucosa where they activate macrophages to 
synthesize IL-1(3 and TNF-a. However, cytokine upregulation induced by previous 
vaccination may contribute to epithelial regeneration. Specifically, IL-IJ3 is considered a 
restitution-promoting cytokine (31). Skin keratinocytes-derived IL-1(3 stimulates the 
production of keratinocyte growth factor (K.GF) by fibroblasts which, in turn favor 
differentiation and proliferation of epithelial cells (32). This mechanism is dependent on the 
transcription factors c-fos and c-jun, which are transcribed as early response genes during 
epithelial restitution and modulate the expression of genes involves in cell migration (33; 34). 
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TGF-P, mRNA expression was increased in immunized and infected pigs. The 
production of this cytokine by T reg cells has been associated with the downregulation of Th 
I responses (7; 35). It has been shown that the same antigens that activate effector cells, can 
also prime regulatory T cells (36; 37). Thus, it is possible that both Thl effector cells and T 
reg cells are present at the colonic mucosa following immunization and challenge. 
Additionally, yô T cells have been implicated in the downregulation of inflammatory 
responses (38-40). Based on immunohistochemical analysis, the numbers of yô T cells were 
not increased in vaccinated pigs, although the loss of yô IEL was less severe than in the non-
immunized and challenged group. It has been shown that yÔ T cells downregulate 
inflammation by inducing apoptosis of activated aP T cells and activated macrophages (41; 
42). Also yô IEL are important in maintaining epithelial homeostasis (43; 44). This subset in 
addition contributes to the process of epithelial wound healing (45). The possible 
contribution of yô T cells in protection against B. hyodysenteriae-induced colitis should be 
addressed in future experiments. Finally, it has been shown that NK and NK-T cells provided 
protection in murine models of colitis (46; 47). NK cells have been characterized in the pig 
as CD3" CD8aa+. In addition, a subset of TCRotP CD8aa* has been identified as part of the 
circulating lymphocyte pool (48; 49). Although CD8aa+ cells were analyzed during the 
course of this study, several cell types within the mucosa express this coreceptor; thus, a 
more specific phenotypic analysis should be performed in order to determine whether the 
composition of NK cells or CD3" CD8aa+ subsets is modulated by infection and/or 
vaccination. 
Mechanisms involved in downregulation of inflammation are impaired in IBD. The 
present study describes an immunization treatment that modulates the course of an 
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inflammatory response. The elucidation of the cellular and molecular mechanisms of action 
of this vaccine could reveal alternative therapies for the treatment of IBD. 
Tabic. I: Histopathological evaluation of colonic lesions of vaccinated and/or infected pigs 
following challenge with Brachyspira hyodysenteriae' 
Category 
Non-infected Infected* 
Non-vaccinated Vaccinated Non-vaccinated Vaccinated 
Gland depth 
HyperVMetapl.5 
Inflammation6 
LP Vasc.change7 
Subm. change8 
Epithelial erosion9 
Total score 10 
8.33 ± 1.11 
0.66 ± 0.44 
1.0 ± 0.0 
0.0 ± 0.0 
0.66 ± 0.44 
0.66 ± 0.44 
11.33 ± 1.85 
7.66 ± 0.88 
1.0 ±0.0 
1.33 ±0.44 
0.0 ± 0.0 
0.66 ± 0.44 
0.66 ±0.44 
11.33 ± 1.33 
13.0 ±2.66* 
2.33 ±0.44* 
1.33 ±0.88 
1.0 ±0.6 
0.66 ± 0.44 
1.33 ±0.88 
19.66 ±4.88 
10.66 ±3.11 
1.66 ± 1.11 
1.33 ±0.44 
0.66 ± 0.8 
0±0.0 
1.33 ± 0.44 
15.66 ±5.7 
' Values represent mean ± SEM (n=3) 
2 Pigs were orally challenged with two doses of 1010 CPU of B. hyodysenteriae strain B204 given on 
consecutive days 
3 Pigs were immunized with three doses of a pepsin-digested preparation of Brachyspira hyodysenteriae at 15 d 
intervals 
4 Gland depth is expressed as a function of crypt width (i.e., a score of 5 indicates that crypts are 5 times as deep 
as they are wide) 
5 Hyperplasia/metaplasia was evaluated as increased cell turnover and basal cell basofilia, or goblet cell 
metaplasia 
6 inflammation was scored based on the presence of cellular infiltrates at the lamina propria 
7 Lamina propria vascular change was evaluated as capillary dilation and/or lamina propria hemorrhage 
8 Submucosal change score is based on the presence of inflammatory foci at the submucosa 
9 Epithelial erosion scores are based on a subjective scale of : 0 = no erosion, 1 = mild erosion, or 2 = severe 
erosion 
10 Total score is the addition of the scores obtained from the previous parameters 
P< 0.05 compared to non-infected groups 
77 
e ti C« 
4-
3-
2 -
1-
TAT 
o-jA 
rti111 
7 12 
Days post-infection 
Non-vacc., non-inf 
... Vacc., non-infected 
- Vacc., inf. 
— Non-vacc., inf. 
Figure 1. Clinical scores of non-vaccinated and non-infected, vaccinated and non-infected, 
vaccinated and infected, and non-vaccinated and infected pigs. Vaccinated pigs received 3 
doses of a pepsin-digested bacterin of B. hyodysenteriae. Pigs were challenged with 2 doses 
of 1010 CPU of B. hyodysenteriae given intragastrically on consecutive days. Diarrhea 
associated with the development of swine dysentery was monitored daily after challenge. 
Scores are based on stool consistency: (0), no diarrhea, stools formed; (1) mild, (2) moderate, 
and (3) severe diarrhea. Clinical scores were calculated by adding diarrhea score (i.e., 0 to 3) 
plus a 1 for the presence of blood and/or a 1 for the presence of mucus represents 
significant differences (P<0.05) between infected groups attributed to the effect of 
vaccination. Values are means ± SEM (n=3), from day 1 to day 13 post infection. 
Figure 2. Photomicrographs of colonic mucosa stained with hematoxylin and eosin. Tissues 
were recovered from non-vaccinated and non-infected (A and E), vaccinated and non-
infected (B and F), vaccinated and infected (C and G), and non-vaccinated and infected pigs 
(D and H) on day 15 post-challenge with B. hyodysenteriae. Inflammation was more severe 
in non-vaccinated and infected pigs (D and H). Protection induced by vaccination resulted in 
lesser mucosal thickening when compared to non-immunized pigs (C and G). Original 
magnification, top panel 63 X, bottom panel 160 X. 
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Figure 3. Photomicrographs of colonic sections from a representative non-vaccinated and 
non-infected pig stained for CD3, CD4 and TCR8 chain by immunohistochemistry. T cells 
are present, both in the lamina proprial and epithelial compartments (A). However, while 
CD4+ cells exist only as lamina propria lymphocytes (B), yô T cells are present in both 
epithelium and lamina propria (C). 
Figure 4. Photomicrographs of colonic sections recovered on day 15 post-challege to depict 
CD4+ T cell distribution in the mucosa. Top panel: CD4+ T cell clusters in the lamina propria 
of non-vaccinated and infected pigs (C) were more abundant than in non-vaccinated and non-
infected (A) or vaccinated and infected pigs (B) (indicated with arrowheads). Original 
magnification, 200 X. Bottom panel: hematoxylixn and eosin staining (D) and 
immunohistochemical staining (E and F) of the basal lamina propria revealed multifocal 
leukocytic infiltrates composed mainly of CD4+ T cells (E). Very few yô T cells were present 
at these inflammatory foci (F). Original magnification, 400 X. 
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Figure 5. Changes in lymphocyte composition induced by vaccination and/or infection with 
Brcichyspira hyodysenteriae. Colonic sections recovered from non-vaccinated and non-
infected, vaccinated and non-infected, vaccinated and infected, or non-vaccinated and 
infected pigs were analyzed by immunohistochemistry for the presence of CD3+, CD4+, 
TCR5+, and CD8a+cells in the lamina propria (A) and epithelium (B). Vaccination reduced 
the numbers of CD4+ lamina propria lymphocytes (*P<0.05). Infected pigs had lower 
numbers of y5 intraepithelial lymphocytes (5 P<0.05), although previous immunization 
ameliorated the loss of this subset. Values are means + SEM (n=3). 
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Figure 6. Detection of cytokine mRNA from colonic tissue using a ribonuclease protection 
assay. Full thickness colonic samples were obtained with a 3 mm-diameter punch biopsy 
from non-vaccinated and infected (1-4), vaccinated and infected (5-8), vaccinated and non-
infected (9-12) and non-vaccinated and non-infected pigs (13-16) at day 15 post-challenge. 
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CHAPTER 4. GENERAL CONCLUSIONS 
The major focus of this dissertation has been the comparison between porcine CD4+ 
and yô T cells. However, the experiments conducted for this aim should be considered within 
the long-term objective of achieving a better understanding of the immune regulation of 
mucosal inflammation. The major strength of utilizing Brachyspira hyodysenteriae-induced 
colitis is the possibility of evaluating systemic and mucosal responses resulting from 
vaccination or infection, respectively. In addition, the fact that swine is among the species 
with large numbers of circulating yô T cells, made it an ideal animal model for conducting 
these studies. 
Intramuscular administration of the B. hyodysenteriae bacterin does not prevent 
infection and, in most of the cases it does not prevent dysentery. However, immunization 
results in a milder disease manifestation as reflected by the clinical signs and microscopic 
lesions described in chapter 3. Due to the functional compartmentalization of the mucosal 
immune system, oral immunization is a requirement in order to mount a protective immune 
response against mucosal pathogens (e.g., production of neutralizing IgA) (1; 2). Of course 
this is not the case here: the route of immunization is not the appropriate to induce this type 
of response, and colonization by the spirochete is not blocked by vaccination. Then, is 
vaccination inducing an anti-inflammatory response rather than an anti-fi. hyodysenteriae 
response? The major effects of vaccination reported here are I) a decrease in CD4+ T cells at 
the colonic mucosa, 2) the 5. hyodysenteriae-induced proliferation of CD4+ and yô T cells in 
vitro, and 3) the upregulation of IL-ip and, TNF-a and TGF-P mRNA expression following 
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infection, at the colonic mucosa. It is therefore expected that these cellular and molecular 
events contribute to the mechanisms of protection. 
Results presented in chapter 2 suggest that a cross-talk between CD4+ and yô T cells 
occurs following stimulation with B. hyodysenteriae antigens, in which IL-2 appears to have 
a synergistic effect. This type of interaction was described in vivo in murine models of 
influenza and listeriosis. In both cases, yô T cells were necessary for downregulating 
inflammation (3-6). Thus it appears that several infectious diseases with an inflammatory 
component trigger this response. Very interestingly, in Lyme disease, which is caused by 
another spirochete, Borrelia burgdorferi, responses of CD41* T cells isolated from synovial 
fluid were downregulated by yô T cells. Lipoproteins from B. burgdorferi were later shown 
to activate yÔ T cells (7; 8). It is evident that CD4+ T cell proliferation described in chapter 2 
is B. hyodysenteriae-spccific. The specificity of the yô T cells is unclear, although it is 
possible that yÔ T cells are responding to B. hyodysenteriae antigens recognized through a 
different mechanism than CD4+. Thus, the capacity of B. hodysenteriae antigens to stimulate 
yô T cells in the absence of CD4+ T cells should be investigated in the future. 
yô T cells induce apoptosis of activated CD4+T cells and macrophages. The 
selectivity for activated cells has been explained on the basis of the high expression level of 
Fas on target cells, whereas yô T cells constitutively express FasL (7; 9). Because 
immunohistochemical analysis did not reveal a significant increase of yô T cells at the 
colonic mucosa of B. hyodysenteriae vaccinated pigs, initially this does not appear to be the 
mechanism that explains the decrease of CD4+ LPL. Alternatively it could be possible that 
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this response took place soon after challenge. A time course study would be necessary to test 
this hypothesis. 
The decrease of CD4^ T cells in protected animals was a preliminary observation 
from previous experiments, which was confirmed here. As it was discussed in chapters 1 and 
2, CD4+ T cells specific for intestinal flora antigens are involved in the pathogenesis of IBD. 
Therefore vaccination had the beneficial effect of lowering a cell type putatively involved in 
the pathogenesis of swine dysentery. Intestinal colonization by B. hyodysenteriae alone is 
insufficient for the development of swine dysentery as it was demonstrated in experiments 
with gnotobiotic pigs, or when mice were treated with antibiotics that eliminated specific 
bacteria from the colonic commensal flora (10-12). Besides the possible interaction described 
above, two additional hypotheses can explain the effect that immunization has on CD4+ LPL. 
First stimulation of regulatory T cells by vaccination. Second, vaccination could partially 
block inflammation (i.e., lower epithelial damage), or accelerate the process of epithelial 
restitution. The upregulation of TGF-Pi mRNA expression is consistent with the stimulation 
of regulatory T cells (13; 14). These results are in agreement with those reported in a murine 
model in which vaccination and infection with B. hyodysenteriae increased antigen-specific 
TGF-P protein levels in mesenteric lymph nodes. Measurement of bioactive TGF-P protein 
in the colon would further support this hypothesis (15). 
Vaccination also upregulated the expression of IL-ip and TNF-a mRNA. The 
implications of these results are intriguing. These cytokines are a hallmark of 
proinflammatory responses, yet they also have a role in epithelial wound healing (16; 17). It 
was previously reported that mice challenged with B. hyodysenteriae upregulated colonic 
TNF-a m RNA 24 hours post-infection. The increased expression of IL-ip did not occurr 
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until 5 days post-infection (12). This is the first study that evaluates the interaction between 
vaccination and infection in regard to the in vivo modulation of cytokine expression. Again, a 
time-course study seems to be necessary in order to determine whether these changes are 
beneficial or, in the contrary, this is a negative effect of the vaccine. The increased 
transcriptional activity of these cytokines, especially of IL-1(3, is most likely due to B. 
hyociysenteriae lipopolysaccharide. Stimulation of murine peritoneal exudate cells or porcine 
alveolar macrophage macrophage with B. hyociysenteriae LPS increased the expression of 
IL-1(3 (18). Evaluation of protection against B. hyociysetitericie-'induced colitis in pigs 
immunizd with a preparation of B. hyociysenteriae LPS would clarify whether the 
upregulation of IL-1(3 mRNA has a beneficial effect. 
Because of their complexity, the use of porcine models for immunological studies has 
the disadvantage of the difficulty in analyzing the role of specific factors within a cellular or 
molecular mechanism. In the case of immunization and or vaccination with B. 
hyociysenteriae, the evaluation of immune responses at the single cell level would aid in 
elucidating the mechanism of action of the vaccine, or the molecular pathogenesis of with B. 
hyociysenteriae-induced colitis. Specifically, in vitro experiments with purified 
subpopulations of yô or CD4+T cells will be necessary for the elucidation of the exact 
mechanism of activation by B. hyociysenteriae antigens or by other stimuli (i.e., IL-2). In 
regards to the regulation of inflammation associated with swine dysentery, there are two 
aspects of major priority: the identification of the cellular source of cytokines involved in 
immune regulation and the expression of molecules that participate in cell-cell interactions at 
the mucosa. 
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